- BCS Dashboard
- Financials
- Filings
- Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
6-K Filing
Barclays (BCS) 6-KAnnual Financial Report
Filed: 23 Feb 22, 1:19pm
BARCLAYS PLC | |
(Registrant) |
By: /s/ Garth Wright -------------------------------- | |
Garth Wright | |
Assistant Secretary |
Results Announcement | Page |
Notes | |
Performance Highlights | |
Group Chief Executive's Review | |
Group Finance Director's Review | |
Results by Business | |
● Barclays UK | 8 |
● Barclays International | 11 |
● Head Office | 16 |
Quarterly Results Summary | 17 |
Quarterly Results by Business | 18 |
Performance Management | |
● Margins and Balances | 24 |
● Remuneration | 26 |
Risk Management | |
● Risk Management and Principal Risks | 28 |
● Credit Risk | 29 |
● Market Risk | 44 |
● Treasury and Capital Risk | 45 |
Statement of Directors’ Responsibilities | 57 |
Condensed Consolidated Financial Statements | 58 |
Financial Statement Notes | 63 |
Appendix: Non-IFRS Performance Measures | 69 |
Shareholder Information | 75 |
C. S. Venkatakrishnan, Group Chief Executive, commented “Barclays demonstrated a clear and sustainable path to growth over the course of 2021, delivering double-digit RoTE across our operating businesses, and returning £2.51 billion of excess capital. Our strategic priorities will continue to develop the diversified business model that we have established, investing in advanced technology capabilities in our consumer businesses, delivering sustainable growth across our global Corporate and Investment Bank, and reinforcing our commitment to aiding the transition to a low-carbon economy.” |
Income | Cost: income ratio | Profit before tax | RoTE | EPS | CET1 ratio | TNAV per share | Total capital return | |
2021 | £21.9bn | 66% | £8.4bn | 13.4% | 37.5p | 15.1% | 292p | 15p equivalent per share1 |
Q421 | £5.2bn | 72% | £1.5bn | 9.3% | 6.6p |
Tushar Morzaria has decided to retire as Group Finance Director and as an Executive Director of Barclays PLC and Barclays Bank PLC, in each case with effect from 22 April 2022. He will be succeeded by Anna Cross, currently Deputy Group Finance Director, who will take up the role of Group Finance Director subject to regulatory approval, and join the Boards of Barclays PLC and Barclays Bank PLC as an Executive Director, in each case with effect from 23 April 2022. Anna will also join the Group Executive Committee, reporting to Group Chief Executive C.S. Venkatakrishnan. |
● | All operating divisions delivered double-digit returns: Barclays UK generated a RoTE of 17.6% (2020: 3.2%) and Barclays International a RoTE of 14.9% (2020: 7.1%), including a 14.9% (2020: 9.5%) RoTE in the Corporate and Investment Bank (CIB) and 15.0% (2020: (7.5)%) RoTE in Consumer, Cards and Payments (CC&P) |
● | Record CIB profitability: profit before tax of £5.8bn, including record Investment Banking fees and Equities income2 |
● | Consumer and payments businesses benefitted from economic recovery: delivered robust UK mortgage lending and deposit growth. Experienced positive trends in UK and US consumer spending and payments volumes |
● | Cost discipline enabled investment for growth: excluding structural cost actions and performance costs, Group total operating expenses were flat at £12.0bn, as efficiency savings were reinvested to drive income growth |
● | Net credit impairment release: £0.7bn release (2020: £4.8bn charge) driven by an improved macroeconomic outlook, reduced unsecured lending balances and benign credit environment. Coverage ratios on unsecured lending remain higher than pre-COVID-19 pandemic levels |
● | Strong capital: Common equity tier 1 (CET1) ratio of 15.1% (December 2020: 15.1%) and tangible net asset value (TNAV) per share increased 9% to 292p |
● | Increased capital distributions: total dividend for 2021 of 6.0p per share (2020: 1.0p), including a 4.0p per share 2021 full year dividend. Intend to initiate a share buyback of up to £1.0bn, bringing the total share buybacks announced in relation to 2021 to £1.5bn and total capital return equivalent to 15p per share |
● | Income: Barclays’ diversified income streams position the Group well for the ongoing economic recovery and rising interest rates |
● | Impairment: impairment charge is expected to remain below pre-COVID-19 pandemic levels in coming quarters given reduced unsecured lending balances and an improved macroeconomic outlook |
● | Costs: Barclays will continue to drive efficiency savings, however, inflationary pressures and planned investment spend are expected to result in FY22 costs, excluding structural cost actions and performance costs being modestly higher than £12.0bn3 |
● | Capital: the CET1 ratio is expected to be impacted by c.80bps of regulatory changes which took effect from 1 January 2022. The announced share buyback of up to £1.0bn will also reduce the CET1 ratio by c.30bps |
● | Capital returns: capital returns policy incorporates a progressive ordinary dividend, supplemented as appropriate, including with share buybacks |
1 | Includes total dividend for 2021 of 6.0p per share and total share buybacks announced in relation to 2021 of £1.5bn. |
2 | On a comparable basis, period covering 2014 – 2021. Pre 2014 financials were not restated following re-segmentation in 2016. |
3 | Group cost outlook is based on an average rate of 1.35 (USD/GBP) in 2022 and subject to foreign currency movements. |
Barclays Group results for the year ended | |||
31.12.21 | 31.12.20 | ||
£m | £m | % Change | |
Net interest income | 8,073 | 8,122 | (1) |
Net fee, commission and other income | 13,867 | 13,644 | 2 |
Total income | 21,940 | 21,766 | 1 |
Credit impairment releases/(charges) | 653 | (4,838) | |
Net operating income | 22,593 | 16,928 | 33 |
Operating costs | (14,092) | (13,434) | (5) |
UK bank levy | (170) | (299) | 43 |
Litigation and conduct | (177) | (153) | (16) |
Total operating expenses | (14,439) | (13,886) | (4) |
Other net income | 260 | 23 | |
Profit before tax | 8,414 | 3,065 | |
Tax charge | (1,188) | (604) | (97) |
Profit after tax | 7,226 | 2,461 | |
Non-controlling interests | (47) | (78) | 40 |
Other equity instrument holders | (804) | (857) | 6 |
Attributable profit | 6,375 | 1,526 | |
Performance measures | |||
Return on average tangible shareholders' equity | 13.4% | 3.2% | |
Average tangible shareholders' equity (£bn) | 47.4 | 48.3 | |
Cost: income ratio | 66% | 64% | |
Loan loss rate (bps) | — | 138 | |
Basic earnings per share | 37.5p | 8.8p | |
Dividend per share | 6.0p | 1.0p | |
Share buyback announced1 (£m) | 1,500 | 700 | |
Total payout equivalent per share | 15.0p | 5.0p | |
Basic weighted average number of shares (m) | 16,985 | 17,300 | (2) |
Period end number of shares (m) | 16,752 | 17,359 | (3) |
Balance sheet and capital management2 | £bn | £bn | |
Loans and advances at amortised cost | 361.5 | 342.6 | 6 |
Loans and advances at amortised cost impairment coverage ratio | 1.6% | 2.4% | |
Deposits at amortised cost | 519.4 | 481.0 | 8 |
Tangible net asset value per share | 292p | 269p | 9 |
Common equity tier 1 ratio | 15.1% | 15.1% | |
Common equity tier 1 capital | 47.5 | 46.3 | |
Risk weighted assets | 314.1 | 306.2 | |
Average UK leverage ratio | 4.9% | 5.0% | |
UK leverage ratio | 5.3% | 5.3% | |
Funding and liquidity | |||
Group liquidity pool (£bn) | 291 | 266 | 9 |
Liquidity coverage ratio | 168% | 162% | |
Loan: deposit ratio | 70% | 71% |
1 | Barclays intends to initiate a share buyback of up to £1.0bn, which is expected to commence in Q122. This brings the total share buybacks announced in relation to FY21 to £1.5bn. |
2 | Refer to pages 48 to 53 for further information on how capital, Risk Weighted Assets (RWAs) and leverage are calculated. |
1 | Top 6 Global Investment Bank supported by #6 ranking in Investment Banking (Source: Dealogic) and #6 ranking in Global Markets (Source: Coalition Greenwich, FY21 Preliminary Competitor analysis). |
2 | Bonds represent debt issuance outstanding for Investment grade (Source: Bloomberg Barclays Global Aggregate Index LEGATRUU) and high yield (Source: Bloomberg Barclays Global High Yield Index LG30TRUU). Equities represents the market capitalisation from all shares outstanding (Source: Bloomberg WCAUWRLD Index). |
3 | Source: Preqin “Future of Alternatives 2025” data excluding Hedge Funds, period covering 2018 – H121. |
1 | $3-5 trillion as estimated in the GFMA/BCG (Global Financial Markets Association/ Boston Consulting Group) Climate Finance Markets and the Real Economy report, December 2020. |
● | Barclays’ diversified business model delivered a record profit before tax of £8,414m (2020: £3,065m), RoTE of 13.4% (2020: 3.2%) and earnings per share (EPS) of 37.5p (2020: 8.8p) |
● | Total income increased to £21,940m (2020: £21,766m). Barclays UK income increased 3%. Barclays International income decreased 2%, with CIB income down 1% and CC&P income down 3%. Excluding the impact of the 8% depreciation of average USD against GBP, total income was up, reflecting Barclays’ diversified income streams |
● | Credit impairment net release of £653m (2020: £4,838m charge). The net release included a reversal of £1.3bn in non-default charges, primarily reflecting the improved macroeconomic outlook. Excluding this reversal, the charge was £0.7bn, reflecting reduced unsecured lending balances and low delinquency. Economic uncertainty adjustments have been maintained firstly in respect of customers and clients who may be more vulnerable to the withdrawal of support schemes and emerging economic uncertainty, and secondly, model uncertainty which does not capture certain macroeconomic and risk parameter uncertainties. The reduction in unsecured lending balances and growth in secured balances have contributed to a decrease in the Group’s loan coverage ratio to 1.6% (December 2020: 2.4%). Coverage ratios in unsecured loan portfolios remained elevated compared to pre-COVID-19 pandemic levels |
● | Total operating expenses increased 4% to £14,439m, due to structural cost actions of £648m primarily relating to the real estate review in Q221 and Barclays UK transformation costs in Q421, higher performance costs that reflect improved returns, and continued investment and business growth. This was partially offset by the benefit from the depreciation of average USD against GBP, efficiency savings and a lower UK bank levy charge, primarily due to the reduced rate. This resulted in a cost: income ratio of 66% (2020: 64%). Excluding structural cost actions of £648m (2020: £368m), operating expenses would have been £13,791m (2020: £13,518m), resulting in a cost: income ratio of 63% (2020: 62%) |
● | The effective tax rate was 14.1% (2020: 19.7%). This reflects a £462m tax benefit recognised for the re-measurement of the Group’s UK deferred tax assets (DTAs) as a result of the enactment in 2021 of a UK corporation tax rate increase from 19% to 25% effective from 1 April 2023 |
● | Attributable profit was £6,375m (2020: £1,526m) |
● | Following the completion of the £700m share buyback announced with FY20 results and the £500m share buyback announced with H121 results, the period end number of shares was 16,752m (December 2020: 17,359m) |
● | Total assets increased to £1,384bn (December 2020: £1,350bn) reflecting a £47bn increase in cash at central banks following strong client deposit growth and a £19bn increase in loans and advances at amortised cost due to increased customer lending |
● | TNAV per share increased to 292p (December 2020: 269p) primarily reflecting 37.5p of EPS, partially offset by negative reserve movements |
● | The CET1 ratio was stable at 15.1% (December 2020: 15.1%) | |
– | CET1 capital increased by £1.2bn to £47.5bn as profit before tax of £8.4bn was partially offset by share buybacks, 2021 dividends and equity coupons paid and foreseen as well as pensions deficit contribution payments | |
– | RWAs increased £7.9bn to £314.1bn primarily resulting from the recalibration of the modelled market risk stress period, increased client and trading activity within CIB and growth in mortgages within Barclays UK, partially offset by lower unsecured balances | |
● | The average UK leverage ratio decreased to 4.9% (December 2020: 5.0%). The average leverage exposure increased by £80.2bn to £1,227.1bn largely driven by an increase in securities financing transactions (SFTs), potential future exposure (PFE) on derivatives and trading portfolio assets (TPAs) |
1 | The 8% depreciation of average USD against GBP adversely impacted income and profits and positively impacted total operating expenses. |
● | The liquidity pool was £291bn (December 2020: £266bn) and the liquidity coverage ratio remained significantly above the 100% regulatory requirement at 168% (December 2020: 162%), equivalent to a surplus of £116bn (December 2020: £99bn). The increase in the pool and surplus was driven by deposit growth, borrowing from the Bank of England’s Term Funding Scheme with additional incentives for small and medium-sized enterprises (SMEs) and an increase in wholesale funding, which were partly offset by an increase in business funding consumption |
● | Wholesale funding outstanding, excluding repurchase agreements, was £167.5bn (December 2020: £145.0bn). The Group issued £11.0bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) during the year. The Group has a strong MREL position with a ratio of 8% of CRR leverage exposures which is in excess of its regulatory requirement of 6.9% |
● | The UK Government has announced that the banking surcharge rate will be reduced from 8% to 3% effective from 1 April 2023. This change has been substantively enacted in Q122 at which point the Group’s UK DTAs will be re-measured and decreased with a resulting tax charge. If this had been enacted by 31 December 2021 it would have resulted in the Group’s UK DTAs being re-measured and decreasing with a tax charge in the income statement of £346m and a tax credit within other comprehensive income of £87m |
● | Barclays is committed to maintaining an appropriate balance between delivering attractive total cash returns to shareholders, investment in the business and maintaining a strong capital position. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividends as appropriate, including with share buybacks |
● | Barclays announces a total dividend for 2021 of 6.0p per share (2020: 1.0p), including a 2021 full year dividend of 4.0p per share to be paid on 5 April 2022. Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal circumstances, around one-third of the total dividend for the year |
● | Barclays intends to initiate a share buyback of up to £1.0bn, which is expected to commence in Q122. This brings the total share buybacks announced in relation to FY21 to £1.5bn |
● | The 6.0p total dividend per share and total share buybacks of £1.5bn in relation to FY21 bring the total capital return equivalent to 15p per share |
● | Returns: RoTE of greater than 10% |
● | Cost efficiency: cost: income ratio below 60% |
● | Capital adequacy: CET1 ratio in the range of 13-14% |
Barclays UK | Year ended | Year ended | |
31.12.21 | 31.12.20 | ||
Income statement information | £m | £m | % Change |
Net interest income | 5,202 | 5,234 | (1) |
Net fee, commission and other income | 1,334 | 1,113 | 20 |
Total income | 6,536 | 6,347 | 3 |
Credit impairment releases/(charges) | 365 | (1,467) | |
Net operating income | 6,901 | 4,880 | 41 |
Operating costs | (4,357) | (4,270) | (2) |
UK bank levy | (36) | (50) | 28 |
Litigation and conduct | (37) | (32) | (16) |
Total operating expenses | (4,430) | (4,352) | (2) |
Other net income | — | 18 | |
Profit before tax | 2,471 | 546 | |
Attributable profit | 1,756 | 325 | |
Balance sheet information | £bn | £bn | |
Loans and advances to customers at amortised cost | 208.8 | 205.4 | |
Total assets | 321.2 | 289.1 | |
Customer deposits at amortised cost | 260.6 | 240.5 | |
Loan: deposit ratio | 85% | 89% | |
Risk weighted assets | 72.3 | 73.7 | |
Period end allocated tangible equity | 10.0 | 9.7 | |
Key facts | |||
Average loan to value of mortgage portfolio1 | 51% | 51% | |
Average loan to value of new mortgage lending1 | 70% | 68% | |
Number of branches | 666 | 859 | |
Mobile banking active customers | 9.7m | 9.2m | |
30 day arrears rate - Barclaycard Consumer UK | 1.0% | 1.7% | |
Performance measures | |||
Return on average allocated tangible equity | 17.6% | 3.2% | |
Average allocated tangible equity (£bn) | 10.0 | 10.1 | |
Cost: income ratio | 68% | 69% | |
Loan loss rate (bps) | — | 68 | |
Net interest margin | 2.52% | 2.61% |
1 | Average loan to value (LTV) of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the Home Loans portfolio. |
Analysis of Barclays UK | Year ended | Year ended | |
31.12.21 | 31.12.20 | ||
Analysis of total income | £m | £m | % Change |
Personal Banking | 3,883 | 3,522 | 10 |
Barclaycard Consumer UK | 1,250 | 1,519 | (18) |
Business Banking | 1,403 | 1,306 | 7 |
Total income | 6,536 | 6,347 | 3 |
Analysis of credit impairment releases/(charges) | |||
Personal Banking | 28 | (380) | |
Barclaycard Consumer UK | 404 | (881) | |
Business Banking | (67) | (206) | 67 |
Total credit impairment releases/(charges) | 365 | (1,467) | |
Analysis of loans and advances to customers at amortised cost | £bn | £bn | |
Personal Banking | 165.4 | 157.3 | |
Barclaycard Consumer UK | 8.7 | 9.9 | |
Business Banking | 34.7 | 38.2 | |
Total loans and advances to customers at amortised cost | 208.8 | 205.4 | |
Analysis of customer deposits at amortised cost | |||
Personal Banking | 196.4 | 179.7 | |
Barclaycard Consumer UK | — | 0.1 | |
Business Banking | 64.2 | 60.7 | |
Total customer deposits at amortised cost | 260.6 | 240.5 |
● | Profit before tax increased to £2,471m (2020: £546m). RoTE was 17.6% (2020: 3.2%) reflecting an improving UK operating environment | |
● | Total income increased 3% to £6,536m. Net interest income reduced 1% to £5,202m with a net interest margin (NIM) of 2.52% (2020: 2.61%) as strong customer retention and improved margins in mortgages were more than offset by lower unsecured lending balances. Net fee, commission and other income increased 20% to £1,334m, returning back towards pre-COVID-19 pandemic levels | |
– | Personal Banking income increased 10% to £3,883m, reflecting strong growth in mortgages, alongside improved margins during the first three quarters, balance growth in deposits and the non-recurrence of COVID-19 customer support actions. This was partially offset by deposit margin compression from lower interest rates and lower unsecured lending balances | |
– | Barclaycard Consumer UK income decreased 18% to £1,250m, as repayments by customers and reduced borrowing resulted in a lower level of interest earning lending (IEL) balances. However, IEL balances began to stabilise throughout H221 | |
– | Business Banking income increased 7% to £1,403m due to lending and deposit balance growth from £12.1bn of government scheme lending and the non-recurrence of COVID-19 and related customer support actions, partially offset by deposit margin compression from lower interest rates | |
● | Credit impairment net release of £365m (2020: £1,467m charge) was driven by an improved macroeconomic outlook and lower unsecured lending balances due to customer repayments and lower delinquencies. As at 31 December 2021, 30 and 90 day arrears rates in UK cards were 1.0% (Q420: 1.7%) and 0.2% (Q420: 0.8%) respectively | |
● | Total operating expenses increased 2% to £4,430m primarily reflecting increased investment spend, including structural cost actions of £288m (2020: £150m). Excluding structural cost actions, operating expenses would have been broadly stable at £4,142m (2020: £4,202m), with higher operational and customer service costs, primarily driven by increased volumes, offset by efficiency savings |
● | Loans and advances to customers at amortised cost increased 2% to £208.8bn predominantly from £9.9bn of mortgage growth following a strong flow of new applications as well as strong customer retention. This was offset by a £2.2bn decrease in the Education, Social Housing and Local Authority (ESHLA) portfolio carrying value as interest rate yield curves steepened, £1.6bn lower unsecured lending balances and £1.3bn lower Business Banking balances as repayment of government scheme lending commences |
● | Customer deposits at amortised cost increased 8% to £260.6bn reflecting an increase of £16.7bn and £3.5bn in Personal Banking and Business Banking respectively, further strengthening the liquidity position and contributing to a loan: deposit ratio of 85% (December 2020: 89%) |
● | RWAs decreased to £72.3bn (December 2020: £73.7bn) driven by a reduction in unsecured lending and the value of the ESHLA portfolio, partially offset by growth in mortgages |
Barclays International | Year ended | Year ended | |
31.12.21 | 31.12.20 | ||
Income statement information | £m | £m | % Change |
Net interest income | 3,263 | 3,282 | (1) |
Net trading income | 5,693 | 6,920 | (18) |
Net fee, commission and other income | 6,709 | 5,719 | 17 |
Total income | 15,665 | 15,921 | (2) |
Credit impairment releases/(charges) | 288 | (3,280) | |
Net operating income | 15,953 | 12,641 | 26 |
Operating costs | (9,076) | (8,765) | (4) |
UK bank levy | (134) | (240) | 44 |
Litigation and conduct | (125) | (48) | |
Total operating expenses | (9,335) | (9,053) | (3) |
Other net income | 40 | 28 | 43 |
Profit before tax | 6,658 | 3,616 | 84 |
Attributable profit | 4,817 | 2,220 | |
Balance sheet information | £bn | £bn | |
Loans and advances at amortised cost | 133.8 | 122.7 | |
Trading portfolio assets | 146.9 | 127.7 | |
Derivative financial instrument assets | 261.5 | 301.8 | |
Financial assets at fair value through the income statement | 188.2 | 170.7 | |
Cash collateral and settlement balances | 88.1 | 97.5 | |
Other assets | 225.6 | 221.4 | |
Total assets | 1,044.1 | 1,041.8 | |
Deposits at amortised cost | 258.8 | 240.5 | |
Derivative financial instrument liabilities | 256.4 | 300.4 | |
Loan: deposit ratio | 52% | 51% | |
Risk weighted assets | 230.9 | 222.3 | |
Period end allocated tangible equity | 33.2 | 30.2 | |
Performance measures | |||
Return on average allocated tangible equity | 14.9% | 7.1% | |
Average allocated tangible equity (£bn) | 32.4 | 31.5 | |
Cost: income ratio | 60% | 57% | |
Loan loss rate (bps) | — | 257 | |
Net interest margin | 4.01% | 3.64% |
Analysis of Barclays International | |||
Corporate and Investment Bank | Year ended | Year ended | |
31.12.21 | 31.12.20 | ||
Income statement information | £m | £m | % Change |
Net interest income | 1,351 | 1,084 | 25 |
Net trading income | 5,652 | 6,975 | (19) |
Net fee, commission and other income | 5,331 | 4,417 | 21 |
Total income | 12,334 | 12,476 | (1) |
Credit impairment releases/(charges) | 473 | (1,559) | |
Net operating income | 12,807 | 10,917 | 17 |
Operating costs | (6,818) | (6,689) | (2) |
UK bank levy | (128) | (226) | 43 |
Litigation and conduct | (17) | (4) | |
Total operating expenses | (6,963) | (6,919) | (1) |
Other net income | 2 | 6 | (67) |
Profit before tax | 5,846 | 4,004 | 46 |
Attributable profit | 4,202 | 2,554 | 65 |
Balance sheet information | £bn | £bn | |
Loans and advances at amortised cost | 100.0 | 92.4 | |
Trading portfolio assets | 146.7 | 127.5 | |
Derivative financial instrument assets | 261.5 | 301.7 | |
Financial assets at fair value through the income statement | 188.1 | 170.4 | |
Cash collateral and settlement balances | 87.2 | 96.7 | |
Other assets | 195.8 | 194.9 | |
Total assets | 979.3 | 983.6 | |
Deposits at amortised cost | 189.4 | 175.2 | |
Derivative financial instrument liabilities | 256.4 | 300.3 | |
Risk weighted assets | 200.7 | 192.2 | |
Performance measures | |||
Return on average allocated tangible equity | 14.9% | 9.5% | |
Average allocated tangible equity (£bn) | 28.3 | 27.0 | |
Cost: income ratio | 56% | 55% | |
Analysis of total income | £m | £m | |
FICC | 3,448 | 5,138 | (33) |
Equities | 2,967 | 2,471 | 20 |
Global Markets | 6,415 | 7,609 | (16) |
Advisory | 921 | 561 | 64 |
Equity capital markets | 813 | 473 | 72 |
Debt capital markets | 1,925 | 1,697 | 13 |
Investment Banking fees | 3,659 | 2,731 | 34 |
Corporate lending | 588 | 590 | — |
Transaction banking | 1,672 | 1,546 | 8 |
Corporate | 2,260 | 2,136 | 6 |
Total income | 12,334 | 12,476 | (1) |
Analysis of Barclays International | |||
Consumer, Cards and Payments | Year ended | Year ended | |
31.12.21 | 31.12.20 | ||
Income statement information | £m | £m | % Change |
Net interest income | 1,912 | 2,198 | (13) |
Net fee, commission, trading and other income | 1,419 | 1,247 | 14 |
Total income | 3,331 | 3,445 | (3) |
Credit impairment charges | (185) | (1,721) | 89 |
Net operating income | 3,146 | 1,724 | 82 |
Operating costs | (2,258) | (2,076) | (9) |
UK bank levy | (6) | (14) | 57 |
Litigation and conduct | (108) | (44) | |
Total operating expenses | (2,372) | (2,134) | (11) |
Other net income | 38 | 22 | 73 |
Profit/(loss) before tax | 812 | (388) | |
Attributable profit/(loss) | 615 | (334) | |
Balance sheet information | £bn | £bn | |
Loans and advances at amortised cost | 33.8 | 30.3 | |
Total assets | 64.8 | 58.2 | |
Deposits at amortised cost | 69.4 | 65.3 | |
Risk weighted assets | 30.2 | 30.1 | |
Key facts | |||
30 day arrears rate – Barclaycard US | 1.6% | 2.5% | |
US cards customer FICO score distribution | |||
<660 | 10% | 13% | |
>660 | 90% | 87% | |
Total number of Barclaycard payments clients | c.380,000 | c.365,000 | |
Value of payments processed (£bn)1 | 277 | 274 | |
Performance measures | |||
Return on average allocated tangible equity | 15.0% | (7.5)% | |
Average allocated tangible equity (£bn) | 4.1 | 4.5 | |
Cost: income ratio | 71% | 62% | |
Loan loss rate (bps) | 51 | 517 | |
Analysis of total income | £m | £m | |
International Cards and Consumer Bank | 2,092 | 2,433 | (14) |
Private Bank | 781 | 707 | 10 |
Unified Payments | 458 | 305 | 50 |
Total income | 3,331 | 3,445 | (3) |
1 | Includes £270bn (2020: £268bn) of merchant acquiring payments. |
● | Profit before tax increased 84% to £6,658m with a RoTE of 14.9% (2020: 7.1%), reflecting a RoTE of 14.9% (2020:9.5%) in CIB and 15.0% (2020: (7.5)%) in CC&P | ||
● | The 8% depreciation of average USD against GBP adversely impacted income and profits and positively impacted total operating expenses | ||
● | Total income decreased to £15,665m (2020: £15,921m) | ||
– | CIB income decreased 1% to £12,334m | ||
– | Global Markets income decreased 16% to £6,415m as a strong performance in Equities, representing the best full year on a comparable basis1, was more than offset by FICC. Equities income increased 20% to £2,967m driven by strong client activity in derivatives and increased client balances in financing. FICC income decreased 33% to £3,448m due to tighter spreads and the non-recurrence of prior year client activity levels | ||
– | Investment Banking fees income, representing the best full year on a comparable basis1, increased 34% to £3,659m driven by a strong performance in Advisory and Equity capital markets reflecting an increase in the fee pool and an increased market share2 | ||
– | Within Corporate, Transaction banking income increased 8% to £1,672m driven by deposits and higher payments volumes. Corporate lending income was stable at £588m (2020: £590m) driven by a current year fair value loan write-off on a single name and increased cost of hedging, whilst the prior year included net losses from the mark-to-market of lending and related hedge positions | ||
– | CC&P income decreased 3% to £3,331m | ||
– | International Cards and Consumer Bank income decreased 14% to £2,092m reflecting lower average cards balances whilst balances increased during H221 | ||
– | Private Bank income increased 10% to £781m, reflecting client balance growth and a gain on a property sale | ||
– | Unified Payments income increased 50% to £458m driven by the non-recurrence of a c.£100m valuation loss on Barclays’ preference shares in Visa Inc. in Q220, which have subsequently been fully disposed of in FY21, and merchant acquiring turnover growth following the easing of lockdown restrictions | ||
● | Credit impairment net release of £288m (2020: £3,280m charge) was driven by an improved macroeconomic outlook | ||
– | CIB credit impairment net release of £473m (2020: £1,559m charge) was also supported by net single name wholesale loan releases and a benign credit environment | ||
– | CC&P credit impairment charge of £185m (2020: £1,721m) was partially driven by lower delinquencies and higher customer repayments. As at 31 December 2021, 30 and 90 day arrears in US cards were 1.6% (Q420: 2.5%) and 0.8% (Q420: 1.4%) respectively | ||
● | Total operating expenses increased 3% to £9,335m | ||
– | CIB total operating expenses increased 1% to £6,963m due to higher performance costs, that reflect an improvement in returns, partly offset by a lower bank levy charge, primarily due to the reduced rate | ||
– | CC&P total operating expenses increased 11% to £2,372m driven by the impact of higher investment spend, including an increase in marketing and costs for existing and new partnerships, and customer remediation costs related to a legacy portfolio |
1 | Period covering 2014 – 2021. Pre 2014 financials were not restated following re-segmentation in 2016. |
2 | Data source: Dealogic for the period covering 1 January to 31 December 2021. |
● | Loans and advances at amortised cost increased £11.1bn to £133.8bn due to increased lending across CIB and CC&P |
● | Trading portfolio assets increased £19.2bn to £146.9bn predominantly due to increased activity in Equities |
● | Derivative financial instruments assets decreased £40.3bn and liabilities decreased £44.0bn to £261.5bn and £256.4bn respectively, driven by an increase in major interest rate curves and reduced client activity in FICC |
● | Financial assets at fair value through the income statement increased £17.5bn to £188.2bn driven by increased secured lending |
● | Cash collateral and settlement balances decreased £9.4bn to £88.1bn |
● | Deposits at amortised cost increased £18.3bn to £258.8bn due to clients increasing liquidity |
● | RWAs increased to £230.9bn (December 2020: £222.3bn) primarily resulting from the recalibration of the modelled market risk stress period, and increased client and trading activity within CIB |
Head Office | Year ended | Year ended | |
31.12.21 | 31.12.20 | ||
Income statement information | £m | £m | % Change |
Net interest income | (392) | (393) | — |
Net fee, commission and other income | 131 | (109) | |
Total income | (261) | (502) | 48 |
Credit impairment charges | — | (91) | |
Net operating income | (261) | (593) | 56 |
Operating costs | (659) | (399) | (65) |
UK bank levy | — | (9) | |
Litigation and conduct | (15) | (73) | 79 |
Total operating expenses | (674) | (481) | (40) |
Other net income/(expenses) | 220 | (23) | |
Loss before tax | (715) | (1,097) | 35 |
Attributable loss | (198) | (1,019) | 81 |
Balance sheet information | £bn | £bn | |
Total assets | 19.0 | 18.6 | |
Risk weighted assets | 11.0 | 10.2 | |
Period end allocated tangible equity | 5.7 | 6.8 | |
Performance measures | |||
Average allocated tangible equity (£bn) | 5.0 | 6.7 |
● | Loss before tax was £715m (2020: £1,097m) |
● | Total income was an expense of £261m (2020: £502m), which primarily reflected hedge accounting, funding costs on legacy capital instruments and treasury items, partially offset by mark-to-market gains on legacy investments and the recognition of dividends on Barclays’ stake in Absa Group Limited |
● | Total operating expenses were £674m (2020: £481m), which included £266m relating to structural cost actions taken as part of the real estate review in Q221, as well as costs associated with the discontinued use of software assets |
● | Other net income was £220m (2020: £23m expense) driven by a fair value gain on investments held by the Business Growth Fund in which Barclays has an associate interest |
● | RWAs were £11.0bn (December 2020: £10.2bn) |
Barclays Group | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | |
Net interest income | 2,230 | 1,940 | 2,052 | 1,851 | 1,845 | 2,055 | 1,892 | 2,331 | |
Net fee, commission and other income | 2,930 | 3,525 | 3,363 | 4,049 | 3,096 | 3,149 | 3,446 | 3,952 | |
Total income | 5,160 | 5,465 | 5,415 | 5,900 | 4,941 | 5,204 | 5,338 | 6,283 | |
Credit impairment releases/(charges) | 31 | (120) | 797 | (55) | (492) | (608) | (1,623) | (2,115) | |
Net operating income | 5,191 | 5,345 | 6,212 | 5,845 | 4,449 | 4,596 | 3,715 | 4,168 | |
Operating costs | (3,514) | (3,446) | (3,587) | (3,545) | (3,480) | (3,391) | (3,310) | (3,253) | |
UK bank levy | (170) | — | — | — | (299) | — | — | — | |
Litigation and conduct | (46) | (32) | (66) | (33) | (47) | (76) | (20) | (10) | |
Total operating expenses | (3,730) | (3,478) | (3,653) | (3,578) | (3,826) | (3,467) | (3,330) | (3,263) | |
Other net income/(expenses) | 13 | 94 | 21 | 132 | 23 | 18 | (26) | 8 | |
Profit before tax | 1,474 | 1,961 | 2,580 | 2,399 | 646 | 1,147 | 359 | 913 | |
Tax charge | (112) | (317) | (263) | (496) | (163) | (328) | (42) | (71) | |
Profit after tax | 1,362 | 1,644 | 2,317 | 1,903 | 483 | 819 | 317 | 842 | |
Non-controlling interests | (27) | (1) | (15) | (4) | (37) | (4) | (21) | (16) | |
Other equity instrument holders | (218) | (197) | (194) | (195) | (226) | (204) | (206) | (221) | |
Attributable profit | 1,117 | 1,446 | 2,108 | 1,704 | 220 | 611 | 90 | 605 | |
Performance measures | |||||||||
Return on average tangible shareholders' equity | 9.3% | 11.9% | 18.1% | 14.7% | 1.8% | 5.1% | 0.7% | 5.1% | |
Average tangible shareholders' equity (£bn) | 48.2 | 48.4 | 46.5 | 46.5 | 47.6 | 48.3 | 50.2 | 47.0 | |
Cost: income ratio | 72% | 64% | 67% | 61% | 77% | 67% | 62% | 52% | |
Loan loss rate (bps) | — | 13 | — | 6 | 56 | 69 | 179 | 223 | |
Basic earnings per share | 6.6p | 8.5p | 12.3p | 9.9p | 1.3p | 3.5p | 0.5p | 3.5p | |
Basic weighted average number of shares (m) | 16,985 | 17,062 | 17,140 | 17,293 | 17,300 | 17,298 | 17,294 | 17,278 | |
Period end number of shares (m) | 16,752 | 16,851 | 16,998 | 17,223 | 17,359 | 17,353 | 17,345 | 17,332 | |
Balance sheet and capital management1 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Loans and advances at amortised cost | 361.5 | 353.0 | 348.5 | 345.8 | 342.6 | 344.4 | 354.9 | 374.1 | |
Loans and advances at amortised cost impairment coverage ratio | 1.6% | 1.7% | 1.8% | 2.2% | 2.4% | 2.5% | 2.5% | 2.1% | |
Total assets | 1,384.3 | 1,406.5 | 1,376.3 | 1,379.7 | 1,349.5 | 1,421.7 | 1,385.1 | 1,444.3 | |
Deposits at amortised cost | 519.4 | 510.2 | 500.9 | 498.8 | 481.0 | 494.6 | 466.9 | 470.7 | |
Tangible net asset value per share | 292p | 287p | 281p | 267p | 269p | 275p | 284p | 284p | |
Common equity tier 1 ratio | 15.1% | 15.4% | 15.1% | 14.6% | 15.1% | 14.6% | 14.2% | 13.1% | |
Common equity tier 1 capital | 47.5 | 47.3 | 46.2 | 45.9 | 46.3 | 45.5 | 45.4 | 42.5 | |
Risk weighted assets | 314.1 | 307.5 | 306.4 | 313.4 | 306.2 | 310.7 | 319.0 | 325.6 | |
Average UK leverage ratio | 4.9% | 4.9% | 4.8% | 4.9% | 5.0% | 5.1% | 4.7% | 4.5% | |
Average UK leverage exposure | 1,227.1 | 1,199.8 | 1,192.0 | 1,174.9 | 1,146.9 | 1,111.1 | 1,148.7 | 1,176.2 | |
UK leverage ratio | 5.3% | 5.1% | 5.0% | 5.0% | 5.3% | 5.2% | 5.2% | 4.5% | |
UK leverage exposure | 1,136.0 | 1,161.0 | 1,153.6 | 1,145.4 | 1,090.9 | 1,095.1 | 1,071.1 | 1,178.7 | |
Funding and liquidity | |||||||||
Group liquidity pool (£bn) | 291 | 293 | 291 | 290 | 266 | 327 | 298 | 237 | |
Liquidity coverage ratio | 168% | 161% | 162% | 161% | 162% | 181% | 186% | 155% | |
Loan: deposit ratio | 70% | 69% | 70% | 69% | 71% | 70% | 76% | 79% |
1 | Refer to pages 48 to 53 for further information on how capital, RWAs and leverage are calculated. |
Barclays UK | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | |
Net interest income | 1,313 | 1,303 | 1,305 | 1,281 | 1,317 | 1,280 | 1,225 | 1,412 | |
Net fee, commission and other income | 386 | 335 | 318 | 295 | 309 | 270 | 242 | 292 | |
Total income | 1,699 | 1,638 | 1,623 | 1,576 | 1,626 | 1,550 | 1,467 | 1,704 | |
Credit impairment releases/(charges) | 59 | (137) | 520 | (77) | (170) | (233) | (583) | (481) | |
Net operating income | 1,758 | 1,501 | 2,143 | 1,499 | 1,456 | 1,317 | 884 | 1,223 | |
Operating costs | (1,202) | (1,041) | (1,078) | (1,036) | (1,134) | (1,095) | (1,018) | (1,023) | |
UK bank levy | (36) | — | — | — | (50) | — | — | — | |
Litigation and conduct | (5) | (10) | (19) | (3) | 4 | (25) | (6) | (5) | |
Total operating expenses | (1,243) | (1,051) | (1,097) | (1,039) | (1,180) | (1,120) | (1,024) | (1,028) | |
Other net (expenses)/income | (1) | 1 | — | — | 6 | (1) | 13 | — | |
Profit/(loss) before tax | 514 | 451 | 1,046 | 460 | 282 | 196 | (127) | 195 | |
Attributable profit/(loss) | 420 | 317 | 721 | 298 | 160 | 113 | (123) | 175 | |
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Loans and advances to customers at amortised cost | 208.8 | 208.6 | 207.8 | 205.7 | 205.4 | 203.9 | 202.0 | 195.7 | |
Total assets | 321.2 | 312.1 | 311.2 | 309.1 | 289.1 | 294.5 | 287.6 | 267.5 | |
Customer deposits at amortised cost | 260.6 | 256.8 | 255.5 | 247.5 | 240.5 | 232.0 | 225.7 | 207.5 | |
Loan: deposit ratio | 85% | 86% | 87% | 88% | 89% | 91% | 92% | 96% | |
Risk weighted assets | 72.3 | 73.2 | 72.2 | 72.7 | 73.7 | 76.2 | 77.9 | 77.7 | |
Period end allocated tangible equity | 10.0 | 10.0 | 9.9 | 10.0 | 9.7 | 10.0 | 10.3 | 10.3 | |
Performance measures | |||||||||
Return on average allocated tangible equity | 16.8% | 12.7% | 29.1% | 12.0% | 6.5% | 4.5% | (4.8)% | 6.9% | |
Average allocated tangible equity (£bn) | 10.0 | 10.0 | 9.9 | 9.9 | 9.8 | 10.1 | 10.3 | 10.1 | |
Cost: income ratio | 73% | 64% | 68% | 66% | 73% | 72% | 70% | 60% | |
Loan loss rate (bps) | — | 24 | — | 14 | 31 | 43 | 111 | 96 | |
Net interest margin | 2.49% | 2.49% | 2.55% | 2.54% | 2.56% | 2.51% | 2.48% | 2.91% |
Analysis of Barclays UK | Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | |
Analysis of total income | £m | £m | £m | £m | £m | £m | £m | £m | |
Personal Banking | 983 | 990 | 987 | 923 | 895 | 833 | 826 | 968 | |
Barclaycard Consumer UK | 352 | 293 | 290 | 315 | 354 | 362 | 367 | 436 | |
Business Banking | 364 | 355 | 346 | 338 | 377 | 355 | 274 | 300 | |
Total income | 1,699 | 1,638 | 1,623 | 1,576 | 1,626 | 1,550 | 1,467 | 1,704 | |
Analysis of credit impairment releases/(charges) | |||||||||
Personal Banking | 8 | (30) | 72 | (22) | (68) | (48) | (130) | (134) | |
Barclaycard Consumer UK | 114 | (108) | 434 | (36) | (78) | (106) | (396) | (301) | |
Business Banking | (63) | 1 | 14 | (19) | (24) | (79) | (57) | (46) | |
Total credit impairment releases/(charges) | 59 | (137) | 520 | (77) | (170) | (233) | (583) | (481) | |
Analysis of loans and advances to customers at amortised cost | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Personal Banking | 165.4 | 164.6 | 162.4 | 160.4 | 157.3 | 155.7 | 154.9 | 153.4 | |
Barclaycard Consumer UK | 8.7 | 8.6 | 8.8 | 8.7 | 9.9 | 10.7 | 11.5 | 13.6 | |
Business Banking | 34.7 | 35.4 | 36.6 | 36.6 | 38.2 | 37.5 | 35.6 | 28.7 | |
Total loans and advances to customers at amortised cost | 208.8 | 208.6 | 207.8 | 205.7 | 205.4 | 203.9 | 202.0 | 195.7 | |
Analysis of customer deposits at amortised cost | |||||||||
Personal Banking | 196.4 | 193.3 | 191.0 | 186.0 | 179.7 | 173.2 | 169.6 | 161.4 | |
Barclaycard Consumer UK | — | — | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | — | |
Business Banking | 64.2 | 63.5 | 64.4 | 61.4 | 60.7 | 58.7 | 56.0 | 46.1 | |
Total customer deposits at amortised cost | 260.6 | 256.8 | 255.5 | 247.5 | 240.5 | 232.0 | 225.7 | 207.5 |
Barclays International | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | |
Net interest income | 955 | 749 | 811 | 748 | 614 | 823 | 847 | 998 | |
Net trading income | 789 | 1,515 | 1,455 | 1,934 | 1,372 | 1,528 | 1,660 | 2,360 | |
Net fee, commission and other income | 1,766 | 1,673 | 1,553 | 1,717 | 1,500 | 1,430 | 1,503 | 1,286 | |
Total income | 3,510 | 3,937 | 3,819 | 4,399 | 3,486 | 3,781 | 4,010 | 4,644 | |
Credit impairment (charges)/releases | (23) | 18 | 271 | 22 | (291) | (370) | (1,010) | (1,609) | |
Net operating income | 3,487 | 3,955 | 4,090 | 4,421 | 3,195 | 3,411 | 3,000 | 3,035 | |
Operating costs | (2,160) | (2,310) | (2,168) | (2,438) | (2,133) | (2,227) | (2,186) | (2,219) | |
UK bank levy | (134) | — | — | — | (240) | — | — | — | |
Litigation and conduct | (38) | (3) | (63) | (21) | (9) | (28) | (11) | — | |
Total operating expenses | (2,332) | (2,313) | (2,231) | (2,459) | (2,382) | (2,255) | (2,197) | (2,219) | |
Other net income | 3 | 15 | 13 | 9 | 9 | 9 | 4 | 6 | |
Profit before tax | 1,158 | 1,657 | 1,872 | 1,971 | 822 | 1,165 | 807 | 822 | |
Attributable profit | 856 | 1,263 | 1,267 | 1,431 | 441 | 782 | 468 | 529 | |
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Loans and advances at amortised cost | 133.8 | 125.9 | 121.9 | 123.5 | 122.7 | 128.0 | 138.1 | 167.0 | |
Trading portfolio assets | 146.9 | 144.8 | 147.1 | 131.1 | 127.7 | 122.3 | 109.5 | 101.6 | |
Derivative financial instrument assets | 261.5 | 257.0 | 255.4 | 269.4 | 301.8 | 295.9 | 306.8 | 341.5 | |
Financial assets at fair value through the income statement | 188.2 | 200.5 | 190.4 | 197.5 | 170.7 | 178.2 | 154.3 | 188.4 | |
Cash collateral and settlement balances | 88.1 | 115.9 | 108.5 | 109.7 | 97.5 | 121.8 | 130.8 | 153.2 | |
Other assets | 225.6 | 231.8 | 223.5 | 221.7 | 221.4 | 261.7 | 236.3 | 201.5 | |
Total assets | 1,044.1 | 1,075.9 | 1,046.8 | 1,052.9 | 1,041.8 | 1,107.9 | 1,075.8 | 1,153.2 | |
Deposits at amortised cost | 258.8 | 253.3 | 245.4 | 251.2 | 240.5 | 262.4 | 241.2 | 263.3 | |
Derivative financial instrument liabilities | 256.4 | 252.3 | 246.9 | 260.2 | 300.4 | 293.3 | 307.6 | 338.8 | |
Loan: deposit ratio | 52% | 50% | 50% | 49% | 51% | 49% | 57% | 63% | |
Risk weighted assets | 230.9 | 222.7 | 223.2 | 230.0 | 222.3 | 224.7 | 231.2 | 237.9 | |
Period end allocated tangible equity | 33.2 | 31.8 | 31.8 | 32.7 | 30.2 | 30.5 | 31.6 | 33.1 | |
Performance measures | |||||||||
Return on average allocated tangible equity | 10.4% | 15.9% | 15.6% | 17.7% | 5.8% | 10.2% | 5.6% | 6.8% | |
Average allocated tangible equity (£bn) | 32.9 | 31.8 | 32.4 | 32.3 | 30.5 | 30.6 | 33.5 | 31.2 | |
Cost: income ratio | 66% | 59% | 58% | 56% | 68% | 60% | 55% | 48% | |
Loan loss rate (bps) | 7 | — | — | (7) | 90 | 112 | 284 | 377 | |
Net interest margin | 4.14% | 4.02% | 3.96% | 3.92% | 3.41% | 3.79% | 3.43% | 3.93% |
Analysis of Barclays International | |||||||||
Corporate and Investment Bank | Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | |
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | |
Net interest income | 432 | 279 | 370 | 270 | 110 | 305 | 334 | 335 | |
Net trading income | 774 | 1,467 | 1,494 | 1,917 | 1,397 | 1,535 | 1,812 | 2,231 | |
Net fee, commission and other income | 1,426 | 1,383 | 1,115 | 1,407 | 1,131 | 1,065 | 1,170 | 1,051 | |
Total income | 2,632 | 3,129 | 2,979 | 3,594 | 2,638 | 2,905 | 3,316 | 3,617 | |
Credit impairment releases/(charges) | 73 | 128 | 229 | 43 | (52) | (187) | (596) | (724) | |
Net operating income | 2,705 | 3,257 | 3,208 | 3,637 | 2,586 | 2,718 | 2,720 | 2,893 | |
Operating costs | (1,562) | (1,747) | (1,623) | (1,886) | (1,603) | (1,716) | (1,680) | (1,690) | |
UK bank levy | (128) | — | — | — | (226) | — | — | — | |
Litigation and conduct | (13) | (2) | (1) | (1) | 2 | (3) | (3) | — | |
Total operating expenses | (1,703) | (1,749) | (1,624) | (1,887) | (1,827) | (1,719) | (1,683) | (1,690) | |
Other net income | 1 | — | — | 1 | 2 | 1 | 3 | — | |
Profit before tax | 1,003 | 1,508 | 1,584 | 1,751 | 761 | 1,000 | 1,040 | 1,203 | |
Attributable profit | 733 | 1,157 | 1,049 | 1,263 | 413 | 627 | 694 | 820 | |
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Loans and advances at amortised cost | 100.0 | 93.8 | 91.0 | 94.3 | 92.4 | 96.8 | 104.9 | 128.2 | |
Trading portfolio assets | 146.7 | 144.7 | 147.0 | 130.9 | 127.5 | 122.2 | 109.3 | 101.5 | |
Derivative financial instruments assets | 261.5 | 256.9 | 255.3 | 269.4 | 301.7 | 295.9 | 306.7 | 341.4 | |
Financial assets at fair value through the income statement | 188.1 | 200.4 | 190.3 | 197.3 | 170.4 | 177.9 | 153.7 | 187.8 | |
Cash collateral and settlement balances | 87.2 | 115.1 | 107.7 | 108.8 | 96.7 | 121.0 | 129.7 | 152.2 | |
Other assets | 195.8 | 200.4 | 192.5 | 190.8 | 194.9 | 228.9 | 205.5 | 171.4 | |
Total assets | 979.3 | 1,011.3 | 983.8 | 991.5 | 983.6 | 1,042.7 | 1,009.8 | 1,082.5 | |
Deposits at amortised cost | 189.4 | 185.8 | 178.2 | 185.2 | 175.2 | 195.6 | 173.9 | 198.4 | |
Derivative financial instrument liabilities | 256.4 | 252.2 | 246.8 | 260.2 | 300.3 | 293.2 | 307.6 | 338.7 | |
Risk weighted assets | 200.7 | 192.5 | 194.3 | 201.3 | 192.2 | 193.3 | 198.3 | 201.7 | |
Performance measures | |||||||||
Return on average allocated tangible equity | 10.2% | 16.6% | 14.8% | 17.9% | 6.3% | 9.5% | 9.6% | 12.5% | |
Average allocated tangible equity (£bn) | 28.7 | 27.8 | 28.4 | 28.2 | 26.3 | 26.4 | 29.0 | 26.2 | |
Cost: income ratio | 65% | 56% | 55% | 53% | 69% | 59% | 51% | 47% | |
Analysis of total income | £m | £m | £m | £m | £m | £m | £m | £m | |
FICC | 546 | 803 | 895 | 1,204 | 812 | 1,000 | 1,468 | 1,858 | |
Equities | 501 | 757 | 777 | 932 | 542 | 691 | 674 | 564 | |
Global Markets | 1,047 | 1,560 | 1,672 | 2,136 | 1,354 | 1,691 | 2,142 | 2,422 | |
Advisory | 287 | 253 | 218 | 163 | 232 | 90 | 84 | 155 | |
Equity capital markets | 158 | 186 | 226 | 243 | 104 | 122 | 185 | 62 | |
Debt capital markets | 511 | 532 | 429 | 453 | 418 | 398 | 463 | 418 | |
Investment Banking fees | 956 | 971 | 873 | 859 | 754 | 610 | 732 | 635 | |
Corporate lending | 176 | 168 | 38 | 206 | 186 | 232 | 61 | 111 | |
Transaction banking | 453 | 430 | 396 | 393 | 344 | 372 | 381 | 449 | |
Corporate | 629 | 598 | 434 | 599 | 530 | 604 | 442 | 560 | |
Total income | 2,632 | 3,129 | 2,979 | 3,594 | 2,638 | 2,905 | 3,316 | 3,617 |
Analysis of Barclays International | |||||||||
Consumer, Cards and Payments | Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | |
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | |
Net interest income | 522 | 471 | 441 | 478 | 504 | 518 | 513 | 663 | |
Net fee, commission, trading and other income | 356 | 337 | 399 | 327 | 344 | 358 | 181 | 364 | |
Total income | 878 | 808 | 840 | 805 | 848 | 876 | 694 | 1,027 | |
Credit impairment (charges)/releases | (96) | (110) | 42 | (21) | (239) | (183) | (414) | (885) | |
Net operating income | 782 | 698 | 882 | 784 | 609 | 693 | 280 | 142 | |
Operating costs | (598) | (563) | (545) | (552) | (530) | (511) | (506) | (529) | |
UK bank levy | (6) | — | — | — | (14) | — | — | — | |
Litigation and conduct | (25) | (1) | (62) | (20) | (11) | (25) | (8) | — | |
Total operating expenses | (629) | (564) | (607) | (572) | (555) | (536) | (514) | (529) | |
Other net income | 2 | 15 | 13 | 8 | 7 | 8 | 1 | 6 | |
Profit/(loss) before tax | 155 | 149 | 288 | 220 | 61 | 165 | (233) | (381) | |
Attributable profit/(loss) | 123 | 106 | 218 | 168 | 28 | 155 | (226) | (291) | |
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Loans and advances at amortised cost | 33.8 | 32.1 | 30.9 | 29.2 | 30.3 | 31.2 | 33.2 | 38.8 | |
Total assets | 64.8 | 64.6 | 63.0 | 61.4 | 58.2 | 65.2 | 66.0 | 70.7 | |
Deposits at amortised cost | 69.4 | 67.5 | 67.2 | 66.0 | 65.3 | 66.8 | 67.3 | 64.9 | |
Risk weighted assets | 30.2 | 30.2 | 29.0 | 28.8 | 30.1 | 31.4 | 32.9 | 36.2 | |
Performance measures | |||||||||
Return on average allocated tangible equity | 11.7% | 10.5% | 21.8% | 16.5% | 2.7% | 14.7% | (20.2)% | (23.5)% | |
Average allocated tangible equity (£bn) | 4.2 | 4.0 | 4.0 | 4.1 | 4.2 | 4.2 | 4.5 | 5.0 | |
Cost: income ratio | 72% | 70% | 72% | 71% | 65% | 61% | 74% | 52% | |
Loan loss rate (bps) | 105 | 127 | — | 27 | 286 | 211 | 455 | 846 | |
Analysis of total income | £m | £m | £m | £m | £m | £m | £m | £m | |
International Cards and Consumer Bank | 552 | 490 | 517 | 533 | 576 | 600 | 567 | 690 | |
Private Bank | 200 | 188 | 214 | 179 | 174 | 171 | 160 | 202 | |
Unified Payments | 126 | 130 | 109 | 93 | 98 | 105 | (33) | 135 | |
Total income | 878 | 808 | 840 | 805 | 848 | 876 | 694 | 1,027 |
Head Office | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | |
Net interest income | (38) | (112) | (64) | (178) | (86) | (48) | (180) | (79) | |
Net fee, commission and other income | (11) | 2 | 37 | 103 | (85) | (79) | 41 | 14 | |
Total income | (49) | (110) | (27) | (75) | (171) | (127) | (139) | (65) | |
Credit impairment (charges)/releases | (5) | (1) | 6 | — | (31) | (5) | (30) | (25) | |
Net operating expenses | (54) | (111) | (21) | (75) | (202) | (132) | (169) | (90) | |
Operating costs | (152) | (95) | (341) | (71) | (213) | (69) | (106) | (11) | |
UK bank levy | — | — | — | — | (9) | — | — | — | |
Litigation and conduct | (3) | (19) | 16 | (9) | (42) | (23) | (3) | (5) | |
Total operating expenses | (155) | (114) | (325) | (80) | (264) | (92) | (109) | (16) | |
Other net income/(expenses) | 11 | 78 | 8 | 123 | 8 | 10 | (43) | 2 | |
Loss before tax | (198) | (147) | (338) | (32) | (458) | (214) | (321) | (104) | |
Attributable (loss)/profit | (159) | (134) | 120 | (25) | (381) | (284) | (255) | (99) | |
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Total assets | 19.0 | 18.5 | 18.3 | 17.7 | 18.6 | 19.3 | 21.7 | 23.6 | |
Risk weighted assets | 11.0 | 11.5 | 11.1 | 10.7 | 10.2 | 9.8 | 9.9 | 10.0 | |
Period end allocated tangible equity | 5.7 | 6.5 | 5.9 | 3.3 | 6.8 | 7.1 | 7.4 | 6.0 | |
Performance measures | |||||||||
Average allocated tangible equity (£bn) | 5.3 | 6.6 | 4.2 | 4.3 | 7.3 | 7.6 | 6.4 | 5.6 | |
Margins and balances | ||||||
Year ended 31.12.21 | Year ended 31.12.20 | |||||
Net interest income | Average customer assets | Net interest margin | Net interest income | Average customer assets | Net interest margin | |
£m | £m | % | £m | £m | % | |
Barclays UK | 5,202 | 206,628 | 2.52 | 5,234 | 200,317 | 2.61 |
Barclays International1 | 3,149 | 78,530 | 4.01 | 3,382 | 92,909 | 3.64 |
Total Barclays UK and Barclays International | 8,351 | 285,158 | 2.93 | 8,616 | 293,226 | 2.94 |
Other2 | (278) | (494) | ||||
Total Barclays Group | 8,073 | 8,122 |
1 | Barclays International margins include IEL balances within the investment banking business. |
2 | Other includes Head Office and non-lending related investment banking businesses not included in Barclays International margins. |
Quarterly analysis for Barclays UK and Barclays International | Net interest income | Average customer assets | Net interest margin |
Three months ended 31.12.21 | £m | £m | % |
Barclays UK | 1,313 | 209,064 | 2.49 |
Barclays International1 | 848 | 81,244 | 4.14 |
Total Barclays UK and Barclays International | 2,161 | 290,308 | 2.95 |
Three months ended 30.09.21 | |||
Barclays UK | 1,303 | 207,692 | 2.49 |
Barclays International1 | 783 | 77,364 | 4.02 |
Total Barclays UK and Barclays International | 2,086 | 285,056 | 2.90 |
Three months ended 30.06.21 | |||
Barclays UK | 1,305 | 205,168 | 2.55 |
Barclays International1 | 763 | 77,330 | 3.96 |
Total Barclays UK and Barclays International | 2,068 | 282,498 | 2.94 |
Three months ended 31.03.21 | |||
Barclays UK | 1,281 | 204,663 | 2.54 |
Barclays International1 | 755 | 78,230 | 3.92 |
Total Barclays UK and Barclays International | 2,036 | 282,893 | 2.92 |
Three months ended 31.12.20 | |||
Barclays UK | 1,317 | 204,315 | 2.56 |
Barclays International1,2 | 696 | 81,312 | 3.41 |
Total Barclays UK and Barclays International | 2,013 | 285,627 | 2.80 |
1 | Barclays International margins include IEL balances within the investment banking business. |
2 | The reclassification of expense of the premium paid for purchased financial guarantees from net investment income to net interest income was recognised in full in Q420 and resulted in a 0.48% reduction on the Q420 Barclays International NIM and 0.14% reduction on the Q420 Total Barclays UK and Barclays International NIM. Had the equivalent impact been reflected in the respective quarters, the Barclays International NIM would have been 3.77% in Q420. Total Barclays UK and Barclays International NIMs would have been 2.91% in Q420. |
Year ended 31.12.21 | Year ended 31.12.20 | ||
£m | £m | % Change | |
Incentive awards granted: | |||
Current year bonus | 1,278 | 1,090 | (17) |
Deferred bonus | 667 | 490 | (36) |
Total incentive awards granted | 1,945 | 1,580 | (23) |
Reconciliation of incentive awards granted to income statement charge: | |||
Less: deferred bonuses granted but not charged in current year | (457) | (335) | (36) |
Add: current year charges for deferred bonuses from previous years | 280 | 293 | 4 |
Other differences between incentive awards granted and income statement charge | (23) | (34) | 32 |
Income statement charge for performance costs | 1,745 | 1,504 | (16) |
Other income statement charges: | |||
Salaries | 4,290 | 4,322 | 1 |
Social security costs | 619 | 613 | (1) |
Post-retirement benefits1 | 539 | 519 | (4) |
Other compensation costs | 431 | 479 | 10 |
Total compensation costs2 | 7,624 | 7,437 | (3) |
Other resourcing costs | |||
Outsourcing | 357 | 342 | (4) |
Redundancy and restructuring | 296 | 102 | |
Temporary staff costs | 109 | 102 | (7) |
Other | 125 | 114 | (10) |
Total other resourcing costs | 887 | 660 | (34) |
Total staff costs | 8,511 | 8,097 | (5) |
Group compensation costs as a % of total income | 34.7 | 34.2 | |
Group staff costs as a % of total income | 38.8 | 37.2 |
1 | Post-retirement benefits charge includes £289m (2020: £279m) in respect of defined contribution schemes and £250m (2020: £240m) in respect of defined benefit schemes. |
2 | £484m (2020: £451m) of Group compensation was capitalised as internally generated software and excluded from the Staff cost disclosed above. |
Actual | Expected1, 2 | ||||
Year ended | Year ended | Year ended | 2023 and | ||
31.12.20 | 31.12.21 | 31.12.22 | beyond | ||
£m | £m | £m | £m | ||
Deferred bonuses from 2018 and earlier bonus pools | 158 | 49 | 9 | 1 | |
Deferred bonuses from 2019 bonus pool | 135 | 92 | 43 | 8 | |
Deferred bonuses from 2020 bonus pool | 155 | 139 | 130 | 67 | |
Deferred bonuses from 2021 bonus pool | — | 210 | 201 | 187 | |
Income statement charge for deferred bonuses | 448 | 490 | 383 | 263 |
1 | The actual amount charged depends upon whether conditions have been met and may vary compared with the above expectation. |
2 | Does not include the impact of grants which will be made in 2022 and beyond. |
Grant date | Expected payment date(s)2 and percentage of the deferred bonus paid | Year | Income statement charge % profile of 2021 onwards3,4 |
March 2022 | 2021 | 35% | |
2022 | 34% | ||
March 2023 (33.3%) | 2023 | 21% | |
March 2024 (33.3%) | 2024 | 9% | |
March 2025 (33.3%) | 2025 | 1% |
1 | Represents a typical vesting schedule for deferred awards. Certain awards may be subject to a 4-, 5- or 7-year deferral in line with regulatory requirements. |
2 | Share awards may be subject to an additional holding period. |
3 | The income statement charge is based on the period over which conditions are met. |
4 | Income statement charge profile % disclosed as a percentage of the award excluding lapse. |
Gross exposure | Impairment allowance | Net exposure | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | |||
As at 31.12.21 | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Barclays UK | 160,695 | 22,779 | 2,915 | 186,389 | 261 | 949 | 728 | 1,938 | 184,451 | |
Barclays International | 25,981 | 2,691 | 1,566 | 30,238 | 603 | 795 | 858 | 2,256 | 27,982 | |
Head Office | 3,735 | 429 | 705 | 4,869 | 2 | 36 | 347 | 385 | 4,484 | |
Total Barclays Group retail | 190,411 | 25,899 | 5,186 | 221,496 | 866 | 1,780 | 1,933 | 4,579 | 216,917 | |
Barclays UK | 35,571 | 1,917 | 969 | 38,457 | 153 | 43 | 111 | 307 | 38,150 | |
Barclays International | 92,341 | 13,275 | 1,059 | 106,675 | 187 | 192 | 458 | 837 | 105,838 | |
Head Office | 542 | 2 | 21 | 565 | — | — | 19 | 19 | 546 | |
Total Barclays Group wholesale1 | 128,454 | 15,194 | 2,049 | 145,697 | 340 | 235 | 588 | 1,163 | 144,534 | |
Total loans and advances at amortised cost | 318,865 | 41,093 | 7,235 | 367,193 | 1,206 | 2,015 | 2,521 | 5,742 | 361,451 | |
Off-balance sheet loan commitments and financial guarantee contracts2 | 312,142 | 34,815 | 1,298 | 348,255 | 217 | 302 | 23 | 542 | 347,713 | |
Total3 | 631,007 | 75,908 | 8,533 | 715,448 | 1,423 | 2,317 | 2,544 | 6,284 | 709,164 | |
As at 31.12.21 | Year ended 31.12.21 | |||||||||
Coverage ratio | Loan impairment charge/(release) and loan loss rate | |||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Loan impairment charge/(release) | Loan loss rate | |||||
% | % | % | % | £m | bps | |||||
Barclays UK | 0.2 | 4.2 | 25.0 | 1.0 | (227) | — | ||||
Barclays International | 2.3 | 29.5 | 54.8 | 7.5 | 181 | 60 | ||||
Head Office | 0.1 | 8.4 | 49.2 | 7.9 | — | — | ||||
Total Barclays Group retail | 0.5 | 6.9 | 37.3 | 2.1 | (46) | — | ||||
Barclays UK | 0.4 | 2.2 | 11.5 | 0.8 | 122 | 32 | ||||
Barclays International | 0.2 | 1.4 | 43.2 | 0.8 | (197) | — | ||||
Head Office | — | — | 90.5 | 3.4 | — | — | ||||
Total Barclays Group wholesale1 | 0.3 | 1.5 | 28.7 | 0.8 | (75) | — | ||||
Total loans and advances at amortised cost | 0.4 | 4.9 | 34.8 | 1.6 | (121) | — | ||||
Off-balance sheet loan commitments and financial guarantee contracts2 | 0.1 | 0.9 | 1.8 | 0.2 | (514) | |||||
Other financial assets subject to impairment3 | (18) | |||||||||
Total | 0.2 | 3.1 | 29.8 | 0.9 | (653) |
1 | Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures, including BBLs of £9.4bn that are managed on a collective basis and reported within BUK Retail. The net impact is a difference in total exposure of £5,993m of balances reported as wholesale loans on page 31 in the Loans and advances at amortised cost by product disclosure. |
2 | Excludes loan commitments and financial guarantees of £18.8bn carried at fair value. |
3 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £107m on £110m Stage 3 other assets. |
Gross exposure | Impairment allowance | Net exposure | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | |||
As at 31.12.20 | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Barclays UK | 153,250 | 23,896 | 2,732 | 179,878 | 332 | 1,509 | 1,147 | 2,988 | 176,890 | |
Barclays International1 | 21,048 | 5,500 | 1,992 | 28,540 | 396 | 1,329 | 1,205 | 2,930 | 25,610 | |
Head Office | 4,267 | 720 | 844 | 5,831 | 4 | 51 | 380 | 435 | 5,396 | |
Total Barclays Group retail | 178,565 | 30,116 | 5,568 | 214,249 | 732 | 2,889 | 2,732 | 6,353 | 207,896 | |
Barclays UK | 31,918 | 4,325 | 1,126 | 37,369 | 13 | 129 | 116 | 258 | 37,111 | |
Barclays International1 | 79,911 | 16,565 | 2,270 | 98,746 | 288 | 546 | 859 | 1,693 | 97,053 | |
Head Office | 570 | — | 33 | 603 | — | — | 31 | 31 | 572 | |
Total Barclays Group wholesale2 | 112,399 | 20,890 | 3,429 | 136,718 | 301 | 675 | 1,006 | 1,982 | 134,736 | |
Total loans and advances at amortised cost | 290,964 | 51,006 | 8,997 | 350,967 | 1,033 | 3,564 | 3,738 | 8,335 | 342,632 | |
Off-balance sheet loan commitments and financial guarantee contracts3 | 289,939 | 52,891 | 2,330 | 345,160 | 256 | 758 | 50 | 1,064 | 344,096 | |
Total4 | 580,903 | 103,897 | 11,327 | 696,127 | 1,289 | 4,322 | 3,788 | 9,399 | 686,728 | |
As at 31.12.20 | Year ended 31.12.20 | |||||||||
Coverage ratio | Loan impairment charge and loan loss rate5 | |||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Loan impairment charge | Loan loss rate | |||||
% | % | % | % | £m | bps | |||||
Barclays UK | 0.2 | 6.3 | 42.0 | 1.7 | 1,070 | 59 | ||||
Barclays International1 | 1.9 | 24.2 | 60.5 | 10.3 | 1,680 | 589 | ||||
Head Office | 0.1 | 7.1 | 45.0 | 7.5 | 91 | 156 | ||||
Total Barclays Group retail | 0.4 | 9.6 | 49.1 | 3.0 | 2,841 | 133 | ||||
Barclays UK | — | 3.0 | 10.3 | 0.7 | 154 | 41 | ||||
Barclays International1 | 0.4 | 3.3 | 37.8 | 1.7 | 914 | 93 | ||||
Head Office | — | — | 93.9 | 5.1 | — | — | ||||
Total Barclays Group wholesale2 | 0.3 | 3.2 | 29.3 | 1.4 | 1,068 | 78 | ||||
Total loans and advances at amortised cost | 0.4 | 7.0 | 41.5 | 2.4 | 3,909 | 111 | ||||
Off-balance sheet loan commitments and financial guarantee contracts3 | 0.1 | 1.4 | 2.1 | 0.3 | 776 | |||||
Other financial assets subject to impairment4 | 153 | |||||||||
Total5 | 0.2 | 4.2 | 33.4 | 1.4 | 4,838 |
1 | Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year. |
2 | Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans on page 31 in the Loans and advances at amortised cost by product disclosure. |
3 | Excludes loan commitments and financial guarantees of £9.5bn carried at fair value. |
4 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m. This comprises £11m ECL on £175.7bn Stage 1 assets, £9m on £4.4bn Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances and £145m on £154m Stage 3 other assets. |
5 | The loan loss rate is 138 bps after applying the total impairment charge of £4,838m. |
Stage 2 | |||||||
As at 31.12.21 | Stage 1 | Not past due | <=30 days past due | >30 days past due | Total | Stage 3 | Total |
Gross exposure | £m | £m | £m | £m | £m | £m | £m |
Home loans | 148,058 | 17,133 | 1,660 | 707 | 19,500 | 2,122 | 169,680 |
Credit cards, unsecured loans and other retail lending | 37,840 | 5,102 | 300 | 248 | 5,650 | 2,332 | 45,822 |
Wholesale loans | 132,967 | 15,246 | 306 | 391 | 15,943 | 2,781 | 151,691 |
Total | 318,865 | 37,481 | 2,266 | 1,346 | 41,093 | 7,235 | 367,193 |
Impairment allowance | |||||||
Home loans | 19 | 46 | 6 | 7 | 59 | 397 | 475 |
Credit cards, unsecured loans and other retail lending | 824 | 1,493 | 85 | 123 | 1,701 | 1,504 | 4,029 |
Wholesale loans | 363 | 248 | 4 | 3 | 255 | 620 | 1,238 |
Total | 1,206 | 1,787 | 95 | 133 | 2,015 | 2,521 | 5,742 |
Net exposure | |||||||
Home loans | 148,039 | 17,087 | 1,654 | 700 | 19,441 | 1,725 | 169,205 |
Credit cards, unsecured loans and other retail lending | 37,016 | 3,609 | 215 | 125 | 3,949 | 828 | 41,793 |
Wholesale loans | 132,604 | 14,998 | 302 | 388 | 15,688 | 2,161 | 150,453 |
Total | 317,659 | 35,694 | 2,171 | 1,213 | 39,078 | 4,714 | 361,451 |
Coverage ratio | % | % | % | % | % | % | % |
Home loans | — | 0.3 | 0.4 | 1.0 | 0.3 | 18.7 | 0.3 |
Credit cards, unsecured loans and other retail lending | 2.2 | 29.3 | 28.3 | 49.6 | 30.1 | 64.5 | 8.8 |
Wholesale loans | 0.3 | 1.6 | 1.3 | 0.8 | 1.6 | 22.3 | 0.8 |
Total | 0.4 | 4.8 | 4.2 | 9.9 | 4.9 | 34.8 | 1.6 |
As at 31.12.20 | |||||||
Gross exposure | £m | £m | £m | £m | £m | £m | £m |
Home loans | 138,639 | 16,651 | 1,785 | 876 | 19,312 | 2,234 | 160,185 |
Credit cards, unsecured loans and other retail lending | 33,021 | 9,470 | 544 | 306 | 10,320 | 3,172 | 46,513 |
Wholesale loans | 119,304 | 19,501 | 1,097 | 776 | 21,374 | 3,591 | 144,269 |
Total | 290,964 | 45,622 | 3,426 | 1,958 | 51,006 | 8,997 | 350,967 |
Impairment allowance | |||||||
Home Loans | 33 | 57 | 13 | 14 | 84 | 421 | 538 |
Credit cards, unsecured loans and other retail lending | 680 | 2,382 | 180 | 207 | 2,769 | 2,251 | 5,700 |
Wholesale Loans | 320 | 650 | 50 | 11 | 711 | 1,066 | 2,097 |
Total | 1,033 | 3,089 | 243 | 232 | 3,564 | 3,738 | 8,335 |
Net exposure | |||||||
Home loans | 138,606 | 16,594 | 1,772 | 862 | 19,228 | 1,813 | 159,647 |
Credit cards, unsecured loans and other retail lending | 32,341 | 7,088 | 364 | 99 | 7,551 | 921 | 40,813 |
Wholesale loans | 118,984 | 18,851 | 1,047 | 765 | 20,663 | 2,525 | 142,172 |
Total | 289,931 | 42,533 | 3,183 | 1,726 | 47,442 | 5,259 | 342,632 |
Coverage ratio | % | % | % | % | % | % | % |
Home loans | — | 0.3 | 0.7 | 1.6 | 0.4 | 18.8 | 0.3 |
Credit cards, unsecured loans and other retail lending | 2.1 | 25.2 | 33.1 | 67.6 | 26.8 | 71.0 | 12.3 |
Wholesale loans | 0.3 | 3.3 | 4.6 | 1.4 | 3.3 | 29.7 | 1.5 |
Total | 0.4 | 6.8 | 7.1 | 11.8 | 7.0 | 41.5 | 2.4 |
Gross exposure | Impairment allowance | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | ||
As at 31.12.21 | £m | £m | £m | £m | £m | £m | £m | £m | |
Air travel | 232 | 201 | 94 | 527 | 9 | 5 | 37 | 51 | |
Hospitality and leisure | 4,898 | 986 | 377 | 6,261 | 26 | 19 | 45 | 90 | |
Oil and gas | 1,765 | 576 | 62 | 2,403 | 14 | 9 | 21 | 44 | |
Retail | 3,901 | 780 | 192 | 4,873 | 38 | 14 | 39 | 91 | |
Shipping | 382 | 201 | 25 | 608 | 9 | 8 | — | 17 | |
Transportation | 1,166 | 417 | 156 | 1,739 | 18 | 9 | 29 | 56 | |
Total | 12,344 | 3,161 | 906 | 16,411 | 114 | 64 | 171 | 349 | |
Total of Wholesale exposures | 9% | 20% | 33% | 11% | 31% | 25% | 28% | 28% | |
Gross exposure | Impairment allowance | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | ||
As at 31.12.20 | £m | £m | £m | £m | £m | £m | £m | £m | |
Air travel | 367 | 525 | 56 | 948 | 9 | 27 | 23 | 59 | |
Hospitality and leisure | 4,440 | 2,387 | 313 | 7,140 | 53 | 115 | 61 | 229 | |
Oil and gas | 1,754 | 854 | 465 | 3,073 | 31 | 27 | 140 | 198 | |
Retail | 3,907 | 1,153 | 283 | 5,343 | 78 | 51 | 108 | 237 | |
Shipping | 308 | 389 | 12 | 709 | 2 | 30 | 1 | 33 | |
Transportation | 1,148 | 253 | 125 | 1,526 | 19 | 10 | 57 | 86 | |
Total | 11,924 | 5,561 | 1,254 | 18,739 | 192 | 260 | 390 | 842 | |
Total of Wholesale exposures | 10% | 26% | 35% | 13% | 60% | 37% | 37% | 40% |
Loans and advances at amortised cost | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | |||||
Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | |
Home loans | £m | £m | £m | £m | £m | £m | £m | £m |
As at 1 January 2021 | 138,639 | 33 | 19,312 | 84 | 2,234 | 421 | 160,185 | 538 |
Transfers from Stage 1 to Stage 2 | (7,672) | (2) | 7,672 | 2 | — | — | — | — |
Transfers from Stage 2 to Stage 1 | 5,336 | 32 | (5,336) | (32) | — | — | — | — |
Transfers to Stage 3 | (282) | — | (469) | (9) | 751 | 9 | — | — |
Transfers from Stage 3 | 35 | 1 | 203 | 5 | (238) | (6) | — | — |
Business activity in the year1 | 32,744 | 7 | 1,243 | 5 | 4 | — | 33,991 | 12 |
Refinements to models used for calculation2 | — | — | — | (4) | — | 38 | — | 34 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (8,131) | (50) | (1,090) | 12 | (216) | (26) | (9,437) | (64) |
Final repayments | (12,039) | (2) | (2,009) | (4) | (392) | (18) | (14,440) | (24) |
Disposals3 | (572) | — | (26) | — | — | — | (598) | — |
Write-offs4 | — | — | — | — | (21) | (21) | (21) | (21) |
As at 31 December 20215 | 148,058 | 19 | 19,500 | 59 | 2,122 | 397 | 169,680 | 475 |
Credit cards, unsecured loans and other retail lending | ||||||||
As at 1 January 2021 | 33,021 | 680 | 10,320 | 2,769 | 3,172 | 2,251 | 46,513 | 5,700 |
Transfers from Stage 1 to Stage 2 | (1,894) | (78) | 1,894 | 78 | — | — | — | — |
Transfers from Stage 2 to Stage 1 | 4,717 | 1,174 | (4,717) | (1,174) | — | — | — | — |
Transfers to Stage 3 | (529) | (22) | (790) | (370) | 1,319 | 392 | — | — |
Transfers from Stage 3 | 55 | 26 | 32 | 19 | (87) | (45) | — | — |
Business activity in the year1 | 7,842 | 119 | 257 | 62 | 42 | 19 | 8,141 | 200 |
Refinements to models used for calculation2 | — | (5) | — | (33) | — | 14 | — | (24) |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes6 | (2,793) | (1,030) | (848) | 389 | (165) | 620 | (3,806) | (21) |
Final repayments | (2,579) | (40) | (498) | (39) | (212) | (92) | (3,289) | (171) |
Disposals3 | — | — | — | — | (287) | (205) | (287) | (205) |
Write-offs4 | — | — | — | — | (1,450) | (1,450) | (1,450) | (1,450) |
As at 31 December 20215 | 37,840 | 824 | 5,650 | 1,701 | 2,332 | 1,504 | 45,822 | 4,029 |
1 | Business activity in the year does not include additional drawdowns on the existing facility which are reported under “Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes”. |
2 | Refinements to models used for calculation include a £34m movement in Home loans, £24m in Credit cards, unsecured loans and other retail lending portfolio and £19m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. |
3 | The £598m disposals reported within Home loans relate to transfer of UK Mortgage facilities to a non consolidated special purpose vehicle for the purpose of securitisation. £287m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a sale of £1.0bn of Barclays Asset Finance and a £0.7bn of debt sales. |
4 | In 2021, gross write-offs amounted to £1,836m (2020: £1,964m) and post write-off recoveries amounted to £66m (2020: £35m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,770m (2020: £1,929m). |
5 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £6m ECL (December 2020: £11m) on £154.9bn stage 1 assets (December 2020: £175.7bn), £1m (December 2020: £9m) on £157m stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 2020: £4.4bn) and £107m (December 2020: £145m) on £110m stage 3 other assets (December 2020: £154m). |
6 | Transfers and risk parameter changes include a £0.3bn (2020: £0.6bn) net release in ECL arising from a reclassification of £1.9bn (2020: £2.0bn) gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending. The reclassification followed a review of back-testing of results which indicated that accuracy of origination probability of default characteristics require management adjustments to correct and was first established in Q220. |
Loans and advances at amortised cost | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | |||||
Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | |
Wholesale loans | £m | £m | £m | £m | £m | £m | £m | £m |
As at 1 January 2021 | 119,304 | 320 | 21,374 | 711 | 3,591 | 1,066 | 144,269 | 2,097 |
Transfers from Stage 1 to Stage 2 | (6,115) | (19) | 6,115 | 19 | — | — | — | — |
Transfers from Stage 2 to Stage 1 | 9,137 | 257 | (9,137) | (257) | — | — | — | — |
Transfers to Stage 3 | (804) | (4) | (377) | (21) | 1,181 | 25 | — | — |
Transfers from Stage 3 | 580 | 23 | 410 | 22 | (990) | (45) | — | — |
Business activity in the year1 | 34,804 | 95 | 1,774 | 18 | 283 | 50 | 36,861 | 163 |
Refinements to models used for calculation2 | — | 8 | — | 11 | — | — | — | 19 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (417) | (268) | 721 | (68) | (211) | 67 | 93 | (269) |
Final repayments | (22,219) | (34) | (4,734) | (174) | (545) | (131) | (27,498) | (339) |
Disposals3 | (1,303) | (15) | (203) | (6) | (163) | (47) | (1,669) | (68) |
Write-offs4 | — | — | — | — | (365) | (365) | (365) | (365) |
As at 31 December 20215 | 132,967 | 363 | 15,943 | 255 | 2,781 | 620 | 151,691 | 1,238 |
Reconciliation of ECL movement to credit impairment (release)/charge for the period | £m | |||||||
Home loans | (42) | |||||||
Credit cards, unsecured loans and other retail lending | (16) | |||||||
Wholesale loans | (426) | |||||||
ECL movement excluding assets derecognised due to disposals and write-offs | (484) | |||||||
Recoveries and reimbursements6 | 240 | |||||||
Exchange and other adjustments7 | 123 | |||||||
Credit impairment release on loan commitments and other financial guarantees | (514) | |||||||
Credit impairment release on other financial assets5 | (18) | |||||||
Credit impairment release for the year | (653) |
1 | Business activity in the year does not include additional drawdowns on the existing facility which are reported under “Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes”. |
2 | Refinements to models used for calculation include a £34m movement in Home Loans, £24m in Credit cards, unsecured loans and other retail lending portfolio and £19m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. |
3 | The £598m disposals reported within Home loans relate to transfer of UK Mortgage facilities to a non consolidated special purpose vehicle for the purpose of securitisation. The £287m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a £1.0bn sale of Barclays Asset Finance and a £0.7bn of debt sales. |
4 | In 2021, gross write-offs amounted to £1,836m (2020: £1,964m) and post write-off recoveries amounted to £66m (2020: £35m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,770m (2020: £1,929m). |
5 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £6m ECL (December 2020: £11m) on £154.9bn stage 1 assets (December 2020: £175.7bn), £1m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 2020: £4.4bn) and £107m (December 2020: £145m) on £110m stage 3 other assets (December 2020: £154m). |
6 | Recoveries and reimbursements includes a net reduction in amounts recoverable from financial guarantee contracts held with third parties of £306m (2020 gain: £364m) and post write off recoveries of £66m (2020: £35m). |
7 | Includes foreign exchange and interest and fees in suspense. |
Loan commitments and financial guarantees | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | |||||
Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | Gross exposure | ECL | |
Home loans | £m | £m | £m | £m | £m | £m | £m | £m |
As at 1 January 2021 | 11,861 | — | 516 | — | 5 | — | 12,382 | — |
Net transfers between stages | (131) | — | 124 | — | 7 | — | — | — |
Business activity in the year | 7,034 | — | — | — | — | — | 7,034 | — |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (7,556) | — | (64) | — | (4) | — | (7,624) | — |
Limit management and final repayments | (375) | — | (44) | — | (5) | — | (424) | — |
As at 31 December 2021 | 10,833 | — | 532 | — | 3 | — | 11,368 | — |
Credit cards, unsecured loans and other retail lending | ||||||||
As at 1 January 2021 | 114,371 | 55 | 12,117 | 305 | 229 | 23 | 126,717 | 383 |
Net transfers between stages | 5,769 | 206 | (6,379) | (213) | 610 | 7 | — | — |
Business activity in the year | 11,206 | — | 430 | — | 2 | — | 11,638 | — |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (742) | (207) | 217 | (24) | (526) | (10) | (1,051) | (241) |
Limit management and final repayments | (7,785) | (4) | (667) | (7) | (97) | — | (8,549) | (11) |
As at 31 December 2021 | 122,819 | 50 | 5,718 | 61 | 218 | 20 | 128,755 | 131 |
Wholesale loans | ||||||||
As at 1 January 2021 | 163,707 | 201 | 40,258 | 453 | 2,096 | 27 | 206,061 | 681 |
Net transfers between stages | 8,227 | 221 | (7,174) | (215) | (1,053) | (6) | — | — |
Business activity in the year | 44,085 | 14 | 4,658 | 102 | 10 | — | 48,753 | 116 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 8,819 | (229) | (151) | 7 | 515 | (11) | 9,183 | (233) |
Limit management and final repayments | (46,348) | (40) | (9,026) | (106) | (491) | (7) | (55,865) | (153) |
As at 31 December 2021 | 178,490 | 167 | 28,565 | 241 | 1,077 | 3 | 208,132 | 411 |
As at 31.12.21 | As at 31.12.20 | |||
Management adjustments to impairment allowances | Proportion of total impairment allowances | Management adjustments to impairment allowances | Proportion of total impairment allowances | |
£m | % | £m | % | |
Home loans | 103 | 21.7 | 131 | 24.3 |
Credit cards, unsecured loans and other retail lending | 1,362 | 32.7 | 1,234 | 20.3 |
Wholesale loans | 21 | 1.3 | 23 | 0.8 |
Total | 1,486 | 23.6 | 1,388 | 14.8 |
1 | Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowances. |
Impairment allowance pre management adjustments2 | Economic uncertainty adjustments (a) | Other adjustments (b) | Total management adjustments (a+b) | Total impairment allowance3 | |
As at 31 December 2021 | £m | £m | £m | £m | £m |
Home loans | 372 | 72 | 31 | 103 | 475 |
Credit cards, unsecured loans and other retail lending | 2,798 | 1,217 | 145 | 1,362 | 4,160 |
Wholesale loans4 | 1,628 | 403 | (382) | 21 | 1,649 |
Total | 4,798 | 1,692 | (206) | 1,486 | 6,284 |
As at 31 December 2020 | |||||
Home loans | 407 | 21 | 110 | 131 | 538 |
Credit cards, unsecured loans and other retail lending | 4,849 | 1,625 | (391) | 1,234 | 6,083 |
Wholesale loans4 | 2,755 | 421 | (398) | 23 | 2,778 |
Total | 8,011 | 2,067 | (679) | 1,388 | 9,399 |
1 | Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance. |
2 | Includes £4.1bn (2020: £6.8bn) of modelled ECL, £0.5bn (2020: £0.9bn) of individually assessed impairments and £0.2bn (2020: £0.3bn) ECL from non-modelled exposures. |
3 | Total impairment allowance consists of ECL stock on drawn and undrawn exposures. |
4 | Other adjustments include £(0.4)bn related to Bounce back loan government guarantee in 2021. In the prior year, the adjustment was £(0.1)bn and was presented under economic uncertainty. |
a. | An adjustment of £0.4bn (2020: £0.7bn) to adjust the probability of default (PDs) to pre-COVID-19 levels to offset the temporary improvement to PDs in light of reduced customer spend behaviour and support measures. The decrease of £0.3bn is primarily driven by some normalisation of customer spending behaviour during the year resulting in a partial release of the PMA. |
b. | A vulnerable customer adjustment of £1.1bn (2020: £1.0bn) has been applied to customers and clients considered potentially vulnerable to the withdrawal of support schemes and emerging economic instability against which lifetime coverage is applied. This is split between credit cards, unsecured loans and other retail lending of £0.8bn (2020: £0.8bn) and wholesale loans of £0.3bn (2020: £0.2bn). The latter includes an adjustment of £0.1bn (2020: £nil) to reflect possible cross default risk on Barclays lending in respect of clients who have taken bounce back loans. |
Baseline average macroeconomic variables used in the calculation of ECL | |||||
2021 | 2022 | 2023 | 2024 | 2025 | |
As at 31 December 2021 | % | % | % | % | % |
UK GDP1 | 6.2 | 4.9 | 2.3 | 1.9 | 1.7 |
UK unemployment2 | 4.8 | 4.7 | 4.5 | 4.3 | 4.2 |
UK HPI3 | 4.7 | 1.0 | 1.9 | 1.9 | 2.3 |
UK bank rate | 0.1 | 0.8 | 1.0 | 1.0 | 0.8 |
US GDP1 | 5.5 | 3.9 | 2.6 | 2.4 | 2.4 |
US unemployment4 | 5.5 | 4.2 | 3.6 | 3.6 | 3.6 |
US HPI5 | 11.8 | 4.5 | 5.2 | 4.9 | 5.0 |
US federal funds rate3 | 0.2 | 0.3 | 0.9 | 1.2 | 1.3 |
2020 | 2021 | 2022 | 2023 | 2024 | |
As at 31 December 2020 | % | % | % | % | % |
UK GDP1 | (10.1) | 6.3 | 3.3 | 2.6 | 2.0 |
UK unemployment2 | 4.5 | 6.7 | 6.4 | 5.8 | 5.1 |
UK HPI3 | 6.1 | 2.4 | 2.3 | 5.0 | 2.4 |
UK bank rate | 0.2 | — | (0.1) | — | 0.1 |
US GDP1 | (4.4) | 3.9 | 3.1 | 2.9 | 2.9 |
US unemployment4 | 8.4 | 6.9 | 5.7 | 5.6 | 5.6 |
US HPI5 | 2.3 | 2.8 | 4.7 | 4.7 | 4.7 |
US federal funds rate3 | 0.5 | 0.3 | 0.3 | 0.3 | 0.4 |
1 | Average Real GDP seasonally adjusted change in year. |
2 | Average UK unemployment rate 16-year+. |
3 | Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. |
4 | Average US civilian unemployment rate 16-year+. |
5 | Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. |
Scenario probability weighting | |||||
Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 | |
% | % | % | % | % | |
As at 31 December 2021 | |||||
Scenario probability weighting | 20.9 | 27.2 | 30.1 | 14.8 | 7.0 |
As at 31 December 2020 | |||||
Scenario probability weighting | 20.2 | 24.2 | 24.7 | 15.5 | 15.4 |
Macroeconomic variables (specific bases)1 | |||||
Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 | |
As at 31 December 2021 | % | % | % | % | % |
UK GDP2 | 21.4 | 18.3 | 3.4 | (1.6) | (1.6) |
UK unemployment3 | 4.0 | 4.1 | 4.5 | 7.0 | 9.2 |
UK HPI4 | 35.7 | 23.8 | 2.4 | (12.7) | (29.9) |
UK bank rate3 | 0.1 | 0.1 | 0.7 | 2.8 | 4.0 |
US GDP2 | 22.8 | 19.6 | 3.4 | 1.5 | (1.3) |
US unemployment3 | 3.3 | 3.5 | 4.1 | 6.8 | 9.5 |
US HPI4 | 53.3 | 45.2 | 6.2 | 2.2 | (5.0) |
US federal funds rate3 | 0.1 | 0.1 | 0.8 | 2.3 | 3.5 |
As at 31 December 2020 | |||||
UK GDP2 | 14.2 | 8.8 | 0.7 | (22.1) | (22.1) |
UK unemployment3 | 4.0 | 4.0 | 5.7 | 8.4 | 10.1 |
UK HPI4 | 48.2 | 30.8 | 3.6 | (4.5) | (18.3) |
UK bank rate3 | 0.1 | 0.1 | — | 0.6 | 0.6 |
US GDP2 | 15.7 | 12.8 | 1.6 | (10.6) | (10.6) |
US unemployment3 | 3.8 | 3.8 | 6.4 | 13.0 | 13.7 |
US HPI4 | 42.2 | 30.9 | 3.8 | (3.7) | (15.9) |
US federal funds rate3 | 0.1 | 0.1 | 0.3 | 1.3 | 1.3 |
1 | UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q121 (2020: Q120). |
2 | Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate (CAGR) in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. |
3 | Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter in 20 quarter period in Downside scenarios. |
4 | Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. |
Macroeconomic variables (5 year averages)1 | |||||
Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 | |
As at 31 December 2021 | % | % | % | % | % |
UK GDP2 | 4.4 | 3.9 | 3.4 | 2.7 | 1.8 |
UK unemployment3 | 4.3 | 4.4 | 4.5 | 5.8 | 7.0 |
UK HPI4 | 6.3 | 4.4 | 2.4 | 0.3 | (2.0) |
UK bank rate3 | 0.3 | 0.5 | 0.7 | 1.7 | 2.3 |
US GDP2 | 4.4 | 3.9 | 3.4 | 2.4 | 1.3 |
US unemployment3 | 3.9 | 4.0 | 4.1 | 5.7 | 7.1 |
US HPI4 | 8.9 | 7.7 | 6.2 | 3.6 | 1.4 |
US federal funds rate3 | 0.5 | 0.6 | 0.8 | 1.5 | 2.1 |
As at 31 December 2020 | |||||
UK GDP2 | 2.5 | 1.6 | 0.7 | 0.1 | (0.9) |
UK unemployment3 | 5.0 | 5.3 | 5.7 | 6.5 | 7.2 |
UK HPI4 | 8.2 | 5.5 | 3.6 | (0.2) | (3.6) |
UK bank rate3 | 0.3 | 0.2 | — | — | (0.1) |
US GDP2 | 2.9 | 2.4 | 1.6 | 0.8 | 0.1 |
US unemployment3 | 5.3 | 5.7 | 6.4 | 8.3 | 10.4 |
US HPI4 | 7.3 | 5.5 | 3.8 | 0.8 | (3.0) |
US federal funds rate3 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 |
1 | UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. |
2 | 5-year yearly average CAGR, starting 2020 (2020: 2019). |
3 | 5-year average. Period based on 20 quarters from Q121 (2020: Q120). |
4 | 5-year quarter end CAGR, starting Q420 (2020: Q419). |
Home loans principal portfolios | Barclays UK | |
As at 31.12.21 | As at 31.12.20 | |
Gross loans and advances (£m) | 158,192 | 148,343 |
90 day arrears rate, excluding recovery book (%) | 0.1 | 0.2 |
Annualised gross charge-off rates - 180 days past due (%) | 0.5 | 0.6 |
Recovery book proportion of outstanding balances (%) | 0.6 | 0.6 |
Recovery book impairment coverage ratio (%) | 4.2 | 3.2 |
Average marked to market LTV | ||
Balance weighted % | 50.7 | 50.7 |
Valuation weighted % | 37.5 | 37.6 |
New lending | Year ended 31.12.21 | Year ended 31.12.20 |
New home loan bookings (£m) | 33,945 | 22,776 |
New home loan proportion > 90% LTV (%) | 1.9 | 2.6 |
Average LTV on new home loans: balance weighted (%) | 69.5 | 67.5 |
Average LTV on new home loans: valuation weighted (%) | 61.9 | 59.6 |
Home loans principal portfolios – distribution of balances by LTV1 | ||||||||||||
Distribution of balances | Distribution of impairment allowance | Coverage ratio | ||||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | |
Barclays UK | % | % | % | % | % | % | % | % | % | % | % | % |
As at 31.12.21 | ||||||||||||
<=75% | 77.2 | 11.3 | 0.7 | 89.2 | 8.3 | 17.7 | 31.9 | 57.9 | — | 0.1 | 2.4 | — |
>75% and <=90% | 9.3 | 0.6 | — | 9.9 | 4.8 | 10.7 | 11.7 | 27.2 | — | 1.0 | 22.6 | 0.1 |
>90% and <=100% | 0.9 | — | — | 0.9 | 0.9 | 1.0 | 2.9 | 4.8 | 0.1 | 1.9 | 87.5 | 0.3 |
>100% | — | — | — | — | 0.2 | 1.0 | 8.9 | 10.1 | 0.4 | 6.4 | 100.0 | 14.1 |
As at 31.12.20 | ||||||||||||
<=75% | 75.7 | 11.6 | 0.6 | 87.9 | 17.9 | 15.0 | 19.0 | 51.9 | — | 0.1 | 1.8 | — |
>75% and <=90% | 10.8 | 0.8 | — | 11.6 | 9.7 | 14.8 | 7.6 | 32.1 | 0.1 | 1.2 | 16.0 | 0.2 |
>90% and <=100% | 0.4 | — | — | 0.4 | 0.8 | 1.5 | 2.2 | 4.5 | 0.1 | 2.6 | 35.7 | 0.7 |
>100% | 0.1 | — | — | 0.1 | 0.7 | 3.4 | 7.4 | 11.5 | 0.7 | 10.3 | 69.1 | 8.0 |
1 | Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 31 December 2021. |
Principal portfolios | Gross exposure | 30 day arrears rate, excluding recovery book | 90 day arrears rate, excluding recovery book | Annualised gross write-off rate | Annualised net write-off rate |
As at 31.12.21 | £m | % | % | % | % |
Barclays UK | |||||
UK cards | 9,933 | 1.0 | 0.2 | 4.1 | 4.0 |
UK personal loans | 4,011 | 1.5 | 0.7 | 3.5 | 3.2 |
Barclays Partner Finance | 2,471 | 0.4 | 0.2 | 1.4 | 1.4 |
Barclays International | |||||
US cards | 17,779 | 1.6 | 0.8 | 4.3 | 4.2 |
Germany consumer lending | 3,559 | 1.5 | 0.7 | 0.9 | 0.8 |
As at 31.12.20 | |||||
Barclays UK | |||||
UK cards | 11,911 | 1.7 | 0.8 | 2.9 | 2.9 |
UK personal loans | 4,591 | 2.3 | 1.2 | 3.4 | 3.1 |
Barclays Partner Finance | 2,469 | 0.5 | 0.3 | 1.1 | 1.1 |
Barclays International | |||||
US cards | 16,845 | 2.5 | 1.4 | 5.6 | 5.6 |
Germany consumer lending | 3,458 | 1.9 | 0.8 | 1.2 | 1.1 |
Management VaR (95%) by asset class | ||||||
31.12.21 | 31.12.20 | |||||
Average | High | Low | Average | High | Low | |
£m | £m | £m | £m | £m | £m | |
Credit risk | 14 | 30 | 7 | 20 | 38 | 10 |
Interest rate risk | 7 | 15 | 4 | 10 | 17 | 6 |
Equity risk | 9 | 29 | 4 | 13 | 35 | 6 |
Basis risk | 6 | 10 | 3 | 10 | 16 | 7 |
Spread risk | 4 | 6 | 3 | 5 | 9 | 3 |
Foreign exchange risk | 4 | 16 | 1 | 5 | 7 | 2 |
Commodity risk | — | 1 | — | 1 | 1 | — |
Inflation risk | 3 | 5 | 2 | 2 | 3 | 1 |
Diversification effect1 | (28) | n/a | n/a | (34) | n/a | n/a |
Total management VaR | 19 | 36 | 6 | 32 | 57 | 18 |
1 | Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table. |
Liquidity coverage ratio | ||
As at 31.12.21 | As at 31.12.20 | |
£bn | £bn | |
Eligible liquidity buffer | 285 | 258 |
Net stress outflows | (169) | (159) |
Surplus | 116 | 99 |
Liquidity coverage ratio | 168% | 162% |
Composition of the Group liquidity pool | |||||
As at 31.12.21 | As at 31.12.20 | ||||
Liquidity pool | Liquidity pool of which CRD IV LCR eligible3 | Liquidity pool | |||
Cash | Level 1 | Level 2A | |||
£bn | £bn | £bn | £bn | £bn | |
Cash and deposits with central banks1 | 245 | 243 | — | — | 197 |
Government bonds2 | |||||
AAA to AA- | 26 | — | 23 | — | 31 |
A+ to A- | 2 | — | — | 2 | 13 |
BBB+ to BBB- | — | — | — | — | 1 |
Total government bonds | 28 | — | 23 | 2 | 45 |
Other | |||||
Government Guaranteed Issuers, PSEs and GSEs | 6 | — | 5 | 1 | 10 |
International Organisations and MDBs | 5 | — | 5 | — | 6 |
Covered bonds | 6 | — | 4 | 2 | 8 |
Other | 1 | — | — | — | — |
Total other | 18 | — | 14 | 3 | 24 |
Total as at 31 December 2021 | 291 | 243 | 37 | 5 | 266 |
Total as at 31 December 2020 | 266 | 192 | 55 | 11 |
1 | Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 99% (December 2020: over 98%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank. |
2 | Of which over 82% (December 2020: over 78%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities. |
3 | The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR (as amended by CRR II) qualifying assets that are not eligible under Barclays’ internal risk appetite. |
Deposit funding | |||||
As at 31.12.21 | As at 31.12.20 | ||||
Loans and advances at amortised cost | Deposits at amortised cost | Loan: deposit ratio1 | Loan: deposit ratio1 | ||
Funding of loans and advances | £bn | £bn | % | % | |
Barclays UK | 222 | 260 | 85 | 89 | |
Barclays International | 134 | 259 | 52 | 51 | |
Head Office | 5 | ||||
Barclays Group | 361 | 519 | 70 | 71 |
1 | The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost. |
Maturity profile of wholesale funding1,2 | |||||||||||
<1 | 1-3 | 3-6 | 6-12 | <1 | 1-2 | 2-3 | 3-4 | 4-5 | >5 | ||
month | months | months | months | year | years | years | years | years | years | Total | |
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |
Barclays PLC (the Parent company) | |||||||||||
Senior unsecured (public benchmark) | — | 0.8 | — | — | 0.8 | 7.4 | 5.5 | 5.5 | 5.8 | 15.6 | 40.6 |
Senior unsecured (privately placed) | — | — | — | — | — | 0.1 | 0.1 | — | — | 1.0 | 1.2 |
Subordinated liabilities | — | — | — | — | — | — | 0.9 | — | 1.5 | 6.8 | 9.2 |
Barclays Bank PLC (including subsidiaries) | |||||||||||
Certificates of deposit and commercial paper | 0.7 | 11.2 | 10.2 | 9.0 | 31.1 | 0.2 | 0.1 | — | — | — | 31.4 |
Asset backed commercial paper | 2.3 | 4.2 | 0.6 | — | 7.1 | — | — | — | — | — | 7.1 |
Senior unsecured (public benchmark) | — | — | 1.3 | — | 1.3 | — | 0.9 | — | — | 0.4 | 2.6 |
Senior unsecured (privately placed)3 | 1.2 | 2.1 | 3.1 | 5.3 | 11.7 | 7.1 | 8.6 | 4.6 | 4.0 | 22.5 | 58.5 |
Asset backed securities | 0.1 | — | — | 0.5 | 0.6 | 0.1 | 2.0 | 0.1 | 0.3 | 1.4 | 4.5 |
Subordinated liabilities | — | 1.0 | — | 1.3 | 2.3 | — | 0.1 | — | 0.4 | 0.8 | 3.6 |
Barclays Bank UK PLC (including subsidiaries) | |||||||||||
Certificates of deposit and commercial paper | 2.9 | 0.2 | 0.5 | — | 3.6 | — | — | — | — | — | 3.6 |
Senior unsecured (public benchmark) | — | — | — | — | — | — | — | — | — | 0.2 | 0.2 |
Covered Bonds | — | 2.2 | — | — | 2.2 | 1.8 | — | — | — | 1.0 | 5.0 |
Total as at 31 December 2021 | 7.2 | 21.7 | 15.7 | 16.1 | 60.7 | 16.7 | 18.2 | 10.2 | 12.0 | 49.7 | 167.5 |
Of which secured | 2.4 | 6.4 | 0.6 | 0.5 | 9.9 | 1.9 | 2.0 | 0.1 | 0.3 | 2.4 | 16.6 |
Of which unsecured | 4.8 | 15.3 | 15.1 | 15.6 | 50.8 | 14.8 | 16.2 | 10.1 | 11.7 | 47.3 | 150.9 |
Total as at 31 December 2020 | 5.7 | 15.4 | 9.5 | 12.1 | 42.7 | 15.6 | 16.7 | 12.3 | 10.2 | 47.5 | 145.0 |
Of which secured | 2.3 | 5.0 | 0.7 | 0.5 | 8.5 | 3.1 | 2.2 | 0.5 | 0.2 | 2.6 | 17.1 |
Of which unsecured | 3.4 | 10.4 | 8.8 | 11.6 | 34.2 | 12.5 | 14.5 | 11.8 | 10.0 | 44.9 | 127.9 |
1 | The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing. |
2 | Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument is more than 1 year. |
3 | Includes structured notes of £50.1bn, of which £10.9bn matures within one year. |
Capital ratios1,2,3 | As at 31.12.21 | As at 30.09.21 | As at 31.12.20 |
CET1 | 15.1% | 15.4% | 15.1% |
Tier 1 (T1) | 19.2% | 19.6% | 19.0% |
Total regulatory capital | 22.3% | 22.9% | 22.1% |
Capital resources | £m | £m | £m |
Total equity excluding non-controlling interests per the balance sheet | 69,222 | 68,697 | 65,797 |
Less: other equity instruments (recognised as AT1 capital) | (12,259) | (12,252) | (11,172) |
Adjustment to retained earnings for foreseeable ordinary share dividends | (666) | (419) | (174) |
Adjustment to retained earnings for foreseeable repurchase of shares | — | (221) | — |
Adjustment to retained earnings for foreseeable other equity coupons | (32) | (51) | (30) |
Other regulatory adjustments and deductions | |||
Additional value adjustments (PVA) | (1,585) | (1,427) | (1,146) |
Goodwill and intangible assets | (6,804) | (6,850) | (6,914) |
Deferred tax assets that rely on future profitability excluding temporary differences | (1,028) | (662) | (595) |
Fair value reserves related to gains or losses on cash flow hedges | 852 | 46 | (1,575) |
Gains or losses on liabilities at fair value resulting from own credit | 892 | 940 | 870 |
Defined benefit pension fund assets | (2,619) | (1,925) | (1,326) |
Direct and indirect holdings by an institution of own CET1 instruments | (50) | (50) | (50) |
Adjustment under IFRS 9 transitional arrangements | 1,229 | 1,332 | 2,556 |
Other regulatory adjustments | 345 | 144 | 55 |
CET1 capital | 47,497 | 47,302 | 46,296 |
AT1 capital | |||
Capital instruments and related share premium accounts | 12,259 | 12,252 | 11,172 |
Qualifying AT1 capital (including minority interests) issued by subsidiaries | 637 | 636 | 646 |
Other regulatory adjustments and deductions | (80) | (80) | (80) |
AT1 capital | 12,816 | 12,808 | 11,738 |
T1 capital | 60,313 | 60,110 | 58,034 |
T2 capital | |||
Capital instruments and related share premium accounts | 8,713 | 8,927 | 7,836 |
Qualifying T2 capital (including minority interests) issued by subsidiaries | 1,113 | 1,306 | 1,893 |
Credit risk adjustments (excess of impairment over expected losses) | 73 | 98 | 57 |
Other regulatory adjustments and deductions | (160) | (160) | (160) |
Total regulatory capital | 70,052 | 70,281 | 67,660 |
Total RWAs | 314,136 | 307,464 | 306,203 |
1 | CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments. |
2 | The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 14.7%, with £46.3bn of CET1 capital and £313.9bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
3 | The Group’s CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 15.1%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017. |
Movement in CET1 capital | Three months ended 31.12.21 | Twelve months ended 31.12.21 |
£m | £m | |
Opening CET1 capital | 47,302 | 46,296 |
Profit for the period attributable to equity holders | 1,335 | 7,179 |
Own credit relating to derivative liabilities | (6) | 16 |
Ordinary share dividends paid and foreseen | (247) | (1,004) |
Purchased and foreseeable share repurchase | — | (1,200) |
Other equity coupons paid and foreseen | (199) | (806) |
Increase in retained regulatory capital generated from earnings | 883 | 4,185 |
Net impact of share schemes | 60 | 187 |
Fair value through other comprehensive income reserve | (120) | (288) |
Currency translation reserve | (68) | (131) |
Other reserves | 5 | (2) |
Decrease in other qualifying reserves | (123) | (234) |
Pension remeasurements within reserves | 717 | 643 |
Defined benefit pension fund asset deduction | (694) | (1,293) |
Net impact of pensions | 23 | (650) |
Additional value adjustments (PVA) | (158) | (439) |
Goodwill and intangible assets | 46 | 110 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences | (366) | (433) |
Adjustment under IFRS 9 transitional arrangements | (103) | (1,327) |
Other regulatory adjustments | (7) | (11) |
Decrease in regulatory capital due to adjustments and deductions | (588) | (2,100) |
Closing CET1 capital | 47,497 | 47,497 |
● | £1bn of dividends paid and foreseen for ordinary shares, which includes £0.3bn half year dividend and a £0.7bn accrual towards the 2021 full year dividend |
● | £1.2bn for share buybacks made up of £0.7bn for the share buyback announced with FY20 results and £0.5bn for the share buyback announced with H121 results; and |
● | £0.8bn of equity coupons paid |
● | A £1.3bn decrease in IFRS 9 transitional relief, after tax, primarily due to credit impairment releases, impairment migrations from Stage 2 to Stage 3 and a decrease to the amount of relief applied to the pre-2020 impairment charge reducing to 50% in 2021 from 70% in 2020 |
● | A £0.7bn decrease as a result of movements relating to pensions, largely due to deficit contribution payments of £0.35bn in April 2021 and September 2021 |
● | A £0.4bn increase in the PVA deduction due to the reversal of temporary COVID-19 relief measures which increased diversification factors applied to certain additional valuation adjustments during 2020 |
RWAs by risk type and business | |||||||||||||
Credit risk | Counterparty credit risk | Market risk | Operational risk | Total RWAs | |||||||||
STD | IRB | STD | IRB | Settlement Risk | CVA | STD | IMA | ||||||
As at 31.12.21 | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |||
Barclays UK | 7,195 | 53,408 | 426 | — | — | 138 | 100 | — | 11,022 | 72,289 | |||
Corporate and Investment Bank | 29,420 | 64,416 | 15,223 | 19,238 | 105 | 2,289 | 17,306 | 27,308 | 25,359 | 200,664 | |||
Consumer, Cards and Payments | 20,770 | 2,749 | 215 | 18 | — | 21 | — | 57 | 6,391 | 30,221 | |||
Barclays International | 50,190 | 67,165 | 15,438 | 19,256 | 105 | 2,310 | 17,306 | 27,365 | 31,750 | 230,885 | |||
Head Office | 4,733 | 7,254 | — | — | — | — | — | — | (1,025) | 10,962 | |||
Barclays Group | 62,118 | 127,827 | 15,864 | 19,256 | 105 | 2,448 | 17,406 | 27,365 | 41,747 | 314,136 | |||
As at 30.09.21 | |||||||||||||
Barclays UK | 7,128 | 53,981 | 464 | — | — | 158 | 115 | — | 11,381 | 73,227 | |||
Corporate and Investment Bank | 26,778 | 70,842 | 17,063 | 19,477 | 211 | 2,347 | 16,399 | 15,934 | 23,453 | 192,504 | |||
Consumer, Cards and Payments | 20,159 | 2,740 | 255 | 30 | — | 37 | — | 44 | 6,948 | 30,213 | |||
Barclays International | 46,937 | 73,582 | 17,318 | 19,507 | 211 | 2,384 | 16,399 | 15,978 | 30,401 | 222,717 | |||
Head Office | 4,984 | 7,344 | — | — | — | — | — | — | (808) | 11,520 | |||
Barclays Group | 59,049 | 134,907 | 17,782 | 19,507 | 211 | 2,542 | 16,514 | 15,978 | 40,974 | 307,464 | |||
As at 31.12.20 | |||||||||||||
Barclays UK | 7,360 | 54,340 | 394 | — | — | 136 | 72 | — | 11,359 | 73,661 | |||
Corporate and Investment Bank | 24,660 | 73,792 | 12,047 | 20,280 | 246 | 2,351 | 13,123 | 22,363 | 23,343 | 192,205 | |||
Consumer, Cards and Payments | 19,754 | 3,041 | 177 | 45 | — | 31 | — | 71 | 6,996 | 30,115 | |||
Barclays International | 44,414 | 76,833 | 12,224 | 20,325 | 246 | 2,382 | 13,123 | 22,434 | 30,339 | 222,320 | |||
Head Office | 4,153 | 6,869 | — | — | — | — | — | — | (800) | 10,222 | |||
Barclays Group | 55,927 | 138,042 | 12,618 | 20,325 | 246 | 2,518 | 13,195 | 22,434 | 40,898 | 306,203 |
Movement analysis of RWAs | |||||
Credit risk | Counterparty credit risk | Market risk | Operational risk | Total RWAs | |
£m | £m | £m | £m | £m | |
Opening RWAs (as at 31.12.20) | 193,969 | 35,707 | 35,629 | 40,898 | 306,203 |
Book size | (1,106) | 1,838 | 1,295 | 849 | 2,876 |
Acquisitions and disposals | (1,095) | — | — | — | (1,095) |
Book quality | 175 | (102) | — | — | 73 |
Model updates | (950) | (186) | 6,927 | — | 5,791 |
Methodology and policy | (345) | 416 | 920 | — | 991 |
Foreign exchange movements1 | (703) | — | — | — | (703) |
Total RWA movements | (4,024) | 1,966 | 9,142 | 849 | 7,933 |
Closing RWAs (as at 31.12.21) | 189,945 | 37,673 | 44,771 | 41,747 | 314,136 |
1 | Foreign exchange movements does not include foreign exchange for counterparty credit risk, market risk or operational risk. |
● | A £1.1bn decrease in book size mainly driven by lower lending, partially offset by growth in mortgages within Barclays UK |
● | A £1.1bn decrease in acquisitions and disposals mainly driven by disposal of wholesale loans during the year |
● | A £1.0bn decrease in model updates primarily due to modelled risk weight recalibrations |
● | A £1.8bn increase in book size primarily due to an increase in client and trading activities within SFTs, partially offset by a reduction in derivatives |
● | A £1.3bn increase in book size primarily due to an increase in client and trading activities |
● | A £6.9bn increase in model updates driven by an increase in Stressed Value at Risk (SVaR) due to a model adjustment to reflect market movements during the COVID-19 stressed period following recalibration of the period, which was delayed until 2021 as a result of COVID-19 relief measures afforded by the PRA |
● | A £0.9bn increase in methodology and policy driven by the application of Pillar 1 Structural FX charge, partially offset by a change in the historical lookback period of the VaR model from two years to one year |
Leverage ratios1,2 | As at 31.12.21 | As at 30.09.21 | As at 31.12.20 |
£m | £m | £m | |
Average UK leverage ratio | 4.9% | 4.9% | 5.0% |
Average T1 capital3 | 59,796 | 58,580 | 57,069 |
Average UK leverage exposure | 1,227,134 | 1,199,774 | 1,146,919 |
UK leverage ratio | 5.3% | 5.1% | 5.3% |
CET1 capital | 47,497 | 47,302 | 46,296 |
AT1 capital | 12,179 | 12,172 | 11,092 |
T1 capital3 | 59,676 | 59,474 | 57,388 |
UK leverage exposure | 1,135,997 | 1,160,983 | 1,090,907 |
UK leverage exposure | |||
Accounting assets | |||
Derivative financial instruments | 262,572 | 258,093 | 302,446 |
Derivative cash collateral | 58,177 | 54,166 | 64,798 |
Securities financing transactions | 170,853 | 190,927 | 164,034 |
Loans and advances and other assets | 892,683 | 903,327 | 818,236 |
Total IFRS assets | 1,384,285 | 1,406,513 | 1,349,514 |
Regulatory consolidation adjustments | (3,665) | (2,192) | (1,144) |
Derivatives adjustments | |||
Derivatives netting | (236,881) | (231,559) | (272,275) |
Adjustments to collateral | (50,929) | (47,490) | (57,414) |
Net written credit protection | 15,509 | 15,910 | 14,986 |
Potential future exposure on derivatives | 137,291 | 143,517 | 117,010 |
Total derivatives adjustments | (135,010) | (119,622) | (197,693) |
SFTs adjustments | 24,544 | 24,579 | 21,114 |
Regulatory deductions and other adjustments | (20,219) | (19,454) | (17,469) |
Weighted off-balance sheet commitments | 113,140 | 115,521 | 113,704 |
Qualifying central bank claims | (210,134) | (198,817) | (155,890) |
Settlement netting | (16,944) | (45,545) | (21,229) |
UK leverage exposure | 1,135,997 | 1,160,983 | 1,090,907 |
1 | Fully loaded average UK leverage ratio was 4.8%, with £58.5bn of T1 capital and £1,225.8bn of leverage exposure. Fully loaded UK leverage ratio was 5.2%, with £58.4bn of T1 capital and £1,134.8bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
2 | Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II. |
3 | T1 capital is calculated in line with the PRA Handbook. |
1 | CRR leverage ratio as amended by CRR II. |
MREL requirements including buffers1,2 | Requirement (£m): | Requirement (%): | |||||
As at 31.12.2021 | As at 30.09.2021 | As at 31.12.2020 | As at 31.12.2021 | As at 30.09.2021 | As at 31.12.2020 | ||
Requirement based on RWAs | 77,302 | 76,174 | 75,918 | 24.6% | 24.8% | 24.8% | |
Requirement based on CRR leverage exposure (minimum requirement) | 93,861 | 94,438 | 87,529 | 6.9% | 6.9% | 7.0% | |
Own funds and eligible liabilities1,2 | £m | £m | £m | ||||
CET1 capital | 47,497 | 47,302 | 46,296 | ||||
AT1 capital instruments and related share premium accounts3 | 12,179 | 12,172 | 11,092 | ||||
T2 capital instruments and related share premium accounts3 | 8,626 | 8,865 | 7,733 | ||||
Eligible liabilities | 39,889 | 38,787 | 35,086 | ||||
Total Barclays PLC (the Parent company) own funds and eligible liabilities | 108,191 | 107,126 | 100,207 | ||||
Total RWAs | 314,136 | 307,464 | 306,203 | ||||
Total CRR leverage exposure | 1,354,284 | 1,368,259 | 1,254,157 | ||||
Own funds and eligible liabilities ratios as a percentage of: | As at 31.12.2021 | As at 30.09.2021 | As at 31.12.2020 | ||||
Total RWAs | 34.4% | 34.8% | 32.7% | ||||
Total CRR leverage exposure | 8.0% | 7.8% | 8.0% |
1 | CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments. |
2 | As at 31 December 2021, Own funds and eligible liabilities including instruments issued by subsidiaries was £109.9bn. |
3 | Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2020: £80m), and other T2 credit risk adjustments and deductions of £87m (December 2020: £103m). |
Impacts due to implementation of regulatory changes - indicative as at 01.01.22 | As at 31.12.21 | Rebased as at 01.01.22 | |||||
£bn | £bn | ||||||
CET1 ratio | 15.1% | 14.3% | |||||
CET1 capital | 47.5 | 45.8 | |||||
Total RWAs1,2 | 314.1 | 320.5 | |||||
UK leverage ratio | 5.3% | 5.3% | |||||
T1 capital | 59.7 | 58.0 | |||||
UK leverage exposure | 1,136.0 | 1,102.1 | |||||
MREL requirement based on UK leverage exposures3 | 87.3 | ||||||
MREL requirement based on RWAs (minimum requirement)3 | 93.6 | ||||||
1 | Includes expected impact on CVA of roll out of SA-CCR across 60 day average period. |
2 | IRB roadmap impact based on latest available data by portfolio, majority is based on 31 December 2021. |
3 | MREL requirement for 31 December 2021 was £93.9bn based on CRR leverage exposures which no longer apply for UK banks from 1 January 2022. |
● | to the best of their knowledge, the condensed consolidated financial statements (set out on pages 58 to 62), which have been prepared in accordance with (a) UK-adopted international accounting standards; and (b) International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), including interpretations issued by the IFRS Interpretations Committee, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole. The condensed consolidated financial statements should be read in conjunction with the annual financial statements as included in the Annual Report for the year ended 31 December 2021; and |
● | to the best of their knowledge, the management information (set out on pages 1 to 56) includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face. This management information should be read in conjunction with the principal risks and uncertainties included in the Annual Report for the year ended 31 December 2021. |
C. S. Venkatakrishnan | Tushar Morzaria | |
Group Chief Executive | Group Finance Director |
Chairman | Executive Directors | Non-Executive Directors |
Nigel Higgins | C. S. Venkatakrishnan Tushar Morzaria | Mike Ashley Robert Berry Tim Breedon CBE Mohamed A. El-Erian Dawn Fitzpatrick Mary Francis CBE Crawford Gillies Brian Gilvary Diane Schueneman Julia Wilson |
Condensed consolidated income statement | |||
Year ended 31.12.21 | Year ended 31.12.20 | ||
Notes1 | £m | £m | |
Interest and similar income | 11,240 | 11,892 | |
Interest and similar expense | (3,167) | (3,770) | |
Net interest income | 8,073 | 8,122 | |
Fee and commission income | 9,880 | 8,641 | |
Fee and commission expense | (2,206) | (2,070) | |
Net fee and commission income | 7,674 | 6,571 | |
Net trading income | 5,794 | 7,029 | |
Net investment income | 311 | 13 | |
Other income | 88 | 31 | |
Total income | 21,940 | 21,766 | |
Credit impairment releases/(charges) | 653 | (4,838) | |
Net operating income | 22,593 | 16,928 | |
Staff costs | (8,511) | (8,097) | |
Infrastructure, administration and general expenses | (5,751) | (5,636) | |
Litigation and conduct | (177) | (153) | |
Operating expenses | (14,439) | (13,886) | |
Share of post-tax results of associates and joint ventures | 260 | 6 | |
Profit on disposal of subsidiaries, associates and joint ventures | — | 17 | |
Profit before tax | 8,414 | 3,065 | |
Tax charge | 1 | (1,188) | (604) |
Profit after tax | 7,226 | 2,461 | |
Attributable to: | |||
Equity holders of the parent | 6,375 | 1,526 | |
Other equity instrument holders | 804 | 857 | |
Total equity holders of the parent | 7,179 | 2,383 | |
Non-controlling interests | 2 | 47 | 78 |
Profit after tax | 7,226 | 2,461 | |
Earnings per share | p | p | |
Basic earnings per ordinary share | 3 | 37.5 | 8.8 |
Diluted earnings per ordinary share | 3 | 36.6 | 8.6 |
1 | For notes to the Financial Statements see pages 63 to 68. |
Condensed consolidated statement of comprehensive income | |||
Year ended 31.12.21 | Year ended 31.12.20 | ||
Notes1 | £m | £m | |
Profit after tax | 7,226 | 2,461 | |
Other comprehensive (loss)/income that may be recycled to profit or loss:2 | |||
Currency translation reserve | 11 | (131) | (473) |
Fair value through other comprehensive income reserve | 11 | (429) | 454 |
Cash flow hedging reserve | 11 | (2,428) | 573 |
Other | 11 | — | 5 |
Other comprehensive (loss)/income that may be recycled to profit or loss | (2,988) | 559 | |
Other comprehensive income/(loss) not recycled to profit or loss:2 | |||
Retirement benefit remeasurements | 8 | 643 | (111) |
Fair value through other comprehensive income reserve | 11 | 141 | (262) |
Own credit | 11 | (14) | (581) |
Other comprehensive income/(loss) not recycled to profit or loss | 770 | (954) | |
Other comprehensive loss for the period | (2,218) | (395) | |
Total comprehensive income for the period | 5,008 | 2,066 | |
Attributable to: | |||
Equity holders of the parent | 4,961 | 1,988 | |
Non-controlling interests | 47 | 78 | |
Total comprehensive income for the period | 5,008 | 2,066 |
1 | For notes to the Financial Statements see pages 63 to 68. |
2 | Reported net of tax. |
Condensed consolidated balance sheet | |||
As at 31.12.21 | As at 31.12.20 | ||
Assets | Notes1 | £m | £m |
Cash and balances at central banks | 238,574 | 191,127 | |
Cash collateral and settlement balances | 92,542 | 101,367 | |
Loans and advances at amortised cost | 361,451 | 342,632 | |
Reverse repurchase agreements and other similar secured lending | 3,227 | 9,031 | |
Trading portfolio assets | 147,035 | 127,950 | |
Financial assets at fair value through the income statement | 191,972 | 175,151 | |
Derivative financial instruments | 262,572 | 302,446 | |
Financial assets at fair value through other comprehensive income | 61,753 | 78,688 | |
Investments in associates and joint ventures | 999 | 781 | |
Goodwill and intangible assets | 8,061 | 7,948 | |
Property, plant and equipment | 3,555 | 4,036 | |
Current tax assets | 261 | 477 | |
Deferred tax assets | 1 | 4,619 | 3,444 |
Retirement benefit assets | 8 | 3,879 | 1,814 |
Other assets | 3,785 | 2,622 | |
Total assets | 1,384,285 | 1,349,514 | |
Liabilities | |||
Deposits at amortised cost | 519,433 | 481,036 | |
Cash collateral and settlement balances | 79,371 | 85,423 | |
Repurchase agreements and other similar secured borrowing | 28,352 | 14,174 | |
Debt securities in issue | 98,867 | 75,796 | |
Subordinated Liabilities | 12,759 | 16,341 | |
Trading portfolio liabilities | 54,169 | 47,405 | |
Financial liabilities designated at fair value | 250,960 | 249,765 | |
Derivative financial instruments | 256,883 | 300,775 | |
Current tax liabilities | 739 | 645 | |
Deferred tax liabilities | 1 | 37 | 15 |
Retirement benefit liabilities | 8 | 311 | 291 |
Other liabilities | 10,505 | 8,662 | |
Provisions | 7 | 1,688 | 2,304 |
Total liabilities | 1,314,074 | 1,282,632 | |
Equity | |||
Called up share capital and share premium | 9 | 4,536 | 4,637 |
Other reserves | 11 | 1,770 | 4,461 |
Retained earnings | 50,657 | 45,527 | |
Shareholders' equity attributable to ordinary shareholders of the parent | 56,963 | 54,625 | |
Other equity instruments | 10 | 12,259 | 11,172 |
Total equity excluding non-controlling interests | 69,222 | 65,797 | |
Non-controlling interests | 2 | 989 | 1,085 |
Total equity | 70,211 | 66,882 | |
Total liabilities and equity | 1,384,285 | 1,349,514 |
1 | For notes to the Financial Statements see pages 63 to 68. |
Condensed consolidated statement of changes in equity | |||||||
Called up share capital and share premium | Other equity instruments | Other reserves | Retained earnings | Total | Non-controlling interests | Total equity | |
Year ended 31.12.2021 | £m | £m | £m | £m | £m | £m | £m |
Balance as at 1 January 2021 | 4,637 | 11,172 | 4,461 | 45,527 | 65,797 | 1,085 | 66,882 |
Profit after tax | — | 804 | — | 6,375 | 7,179 | 47 | 7,226 |
Retirement benefit remeasurements | — | — | — | 643 | 643 | — | 643 |
Other comprehensive profit after tax for the year | — | — | (2,861) | — | (2,861) | — | (2,861) |
Total comprehensive income for the period | — | 804 | (2,861) | 7,018 | 4,961 | 47 | 5,008 |
Employee share schemes and hedging thereof | 60 | — | — | 235 | 295 | — | 295 |
Issue and redemption of other equity instruments | — | 1,078 | — | 6 | 1,084 | (75) | 1,009 |
Other equity instruments coupon paid | — | (804) | — | — | (804) | — | (804) |
Vesting of employee share schemes | — | — | 1 | (410) | (409) | — | (409) |
Dividends paid | — | — | — | (512) | (512) | (44) | (556) |
Repurchase of shares | (161) | — | 161 | (1,200) | (1,200) | — | (1,200) |
Other movements | — | 9 | 8 | (7) | 10 | (24) | (14) |
Balance as at 31 December 2021 | 4,536 | 12,259 | 1,770 | 50,657 | 69,222 | 989 | 70,211 |
Year ended 31.12.2020 | |||||||
Balance as at 1 January 2020 | 4,594 | 10,871 | 4,760 | 44,204 | 64,429 | 1,231 | 65,660 |
Profit after tax | — | 857 | — | 1,526 | 2,383 | 78 | 2,461 |
Retirement benefit remeasurements | — | — | — | (111) | (111) | — | (111) |
Other comprehensive profit after tax for the year | — | — | (289) | 5 | (284) | — | (284) |
Total comprehensive income for the period | — | 857 | (289) | 1,420 | 1,988 | 78 | 2,066 |
Employee share schemes and hedging thereof | 43 | — | — | 303 | 346 | — | 346 |
Issue and redemption of other equity instruments | — | 311 | — | (55) | 256 | (158) | 98 |
Other equity instruments coupon paid | — | (857) | — | — | (857) | — | (857) |
Vesting of shares under employee share schemes | — | — | (10) | (347) | (357) | — | (357) |
Dividends paid | — | — | — | — | — | (79) | (79) |
Other movements | — | (10) | — | 2 | (8) | 13 | 5 |
Balance as at 31 December 2020 | 4,637 | 11,172 | 4,461 | 45,527 | 65,797 | 1,085 | 66,882 |
Condensed consolidated cash flow statement | ||
Year ended 31.12.21 | Year ended 31.12.20 | |
£m | £m | |
Profit before tax | 8,414 | 3,065 |
Adjustment for non-cash items | 4,803 | 5,007 |
Net increase in loans and advances at amortised cost | (10,728) | (4,365) |
Net increase in deposits at amortised cost | 38,397 | 65,249 |
Net increase/(decrease) in debt securities in issue | 18,131 | (6,309) |
Changes in other operating assets and liabilities | (8,763) | (4,459) |
Corporate income tax paid | (1,335) | (683) |
Net cash from operating activities | 48,919 | 57,505 |
Net cash from investing activities | 4,270 | (18,376) |
Net cash from financing activities | 107 | 2,732 |
Effect of exchange rates on cash and cash equivalents | (4,232) | 1,668 |
Net increase/(decrease) in cash and cash equivalents | 49,064 | 43,529 |
Cash and cash equivalents at beginning of the period | 210,142 | 166,613 |
Cash and cash equivalents at end of the period | 259,206 | 210,142 |
As at 31.12.21 | As at 31.12.20 | |
Deferred tax assets and liabilities | £m | £m |
UK | 2,183 | 886 |
USA | 2,006 | 2,049 |
Other territories | 430 | 509 |
Deferred tax assets | 4,619 | 3,444 |
Deferred tax liabilities | (37) | (15) |
Analysis of deferred tax assets | ||
Temporary differences | 3,399 | 2,709 |
Tax losses | 1,220 | 735 |
Deferred tax assets | 4,619 | 3,444 |
Profit attributable to non-controlling interests | Equity attributable to non-controlling interests | ||||
Year ended 31.12.21 | Year ended 31.12.20 | As at 3 1.12.21 | As at 3 1.12.20 | ||
£m | £m | £m | £m | ||
Barclays Bank PLC issued: | |||||
- Preference shares | 27 | 42 | 529 | 529 | |
- Upper T2 instruments | 17 | 37 | 458 | 533 | |
Other non-controlling interests | 3 | (1) | 2 | 23 | |
Total | 47 | 78 | 989 | 1,085 |
Year ended 31.12.21 | Year ended 31.12.20 | |
£m | £m | |
Profit attributable to ordinary equity holders of the parent | 6,375 | 1,526 |
m | m | |
Basic weighted average number of shares in issue | 16,985 | 17,300 |
Number of potential ordinary shares | 435 | 368 |
Diluted weighted average number of shares | 17,420 | 17,668 |
p | p | |
Basic earnings per ordinary share | 37.5 | 8.8 |
Diluted earnings per ordinary share | 36.6 | 8.6 |
Year ended 31.12.21 | Year ended 31.12.20 | |||
Per share | Total | Per share | Total | |
Dividends paid during the period | p | £m | p | £m |
Full year dividend paid during period | 1.0 | 173 | — | — |
Half year dividend paid during period | 2.0 | 339 | — | — |
Total dividend | 3.0 | 512 | — | — |
Valuation technique using | ||||
Quoted market prices | Observable inputs | Significant unobservable inputs | ||
(Level 1) | (Level 2) | (Level 3) | Total | |
As at 31.12.21 | £m | £m | £m | £m |
Trading portfolio assets | 80,926 | 63,828 | 2,281 | 147,035 |
Financial assets at fair value through the income statement | 5,093 | 177,167 | 9,712 | 191,972 |
Derivative financial instruments | 6,150 | 252,412 | 4,010 | 262,572 |
Financial assets at fair value through other comprehensive income | 22,009 | 39,706 | 38 | 61,753 |
Investment property | — | — | 7 | 7 |
Total assets | 114,178 | 533,113 | 16,048 | 663,339 |
Trading portfolio liabilities | (27,529) | (26,613) | (27) | (54,169) |
Financial liabilities designated at fair value | (174) | (250,376) | (410) | (250,960) |
Derivative financial instruments | (6,571) | (244,253) | (6,059) | (256,883) |
Total liabilities | (34,274) | (521,242) | (6,496) | (562,012) |
As at 31.12.20 | ||||
Trading portfolio assets | 60,671 | 65,416 | 1,863 | 127,950 |
Financial assets at fair value through the income statement | 4,503 | 162,142 | 8,506 | 175,151 |
Derivative financial instruments | 9,155 | 288,822 | 4,469 | 302,446 |
Financial assets at fair value through other comprehensive income | 19,792 | 58,743 | 153 | 78,688 |
Investment property | — | — | 10 | 10 |
Total assets | 94,121 | 575,123 | 15,001 | 684,245 |
Trading portfolio liabilities | (24,391) | (22,986) | (28) | (47,405) |
Financial liabilities designated at fair value | (159) | (249,251) | (355) | (249,765) |
Derivative financial instruments | (8,762) | (285,774) | (6,239) | (300,775) |
Total liabilities | (33,312) | (558,011) | (6,622) | (597,945) |
Year ended 31.12.21 | Year ended 31.12.20 | |
£m | £m | |
Opening balance as at 1 January | 16,341 | 18,156 |
Issuances | 1,890 | 1,438 |
Redemptions | (4,807) | (3,464) |
Other | (665) | 211 |
Closing balance | 12,579 | 16,341 |
As at 31.12.21 | As at 31.12.20 | |
£m | £m | |
Customer redress | 310 | 497 |
Legal, competition and regulatory matters | 226 | 268 |
Redundancy and restructuring | 326 | 158 |
Undrawn contractually committed facilities and guarantees1 | 542 | 1,064 |
Onerous contracts | 5 | 28 |
Sundry provisions | 279 | 289 |
Total | 1,688 | 2,304 |
1 | Undrawn contractually committed facilities and guarantees provisions are accounted for under IFRS 9. |
Ordinary share capital | Share premium | Total share capital and share premium | |
Year ended 31.12.21 | £m | £m | £m |
Opening balance as at 1 January | 4,340 | 297 | 4,637 |
Issue of shares under employee share schemes | 9 | 51 | 60 |
Repurchase of shares | (161) | — | (161) |
Closing balance | 4,188 | 348 | 4,536 |
Year ended 31.12.21 | Year ended 31.12.20 | |
£m | £m | |
Opening balance as at 1 January | 11,172 | 10,871 |
Issuances | 1,078 | 1,142 |
Redemptions | — | (831) |
Securities held by the Group | 9 | (10) |
Closing balance | 12,259 | 11,172 |
As at 31.12.21 | As at 31.12.20 | |
£m | £m | |
Currency translation reserve | 2,740 | 2,871 |
Fair value through other comprehensive income reserve | (283) | 5 |
Cash flow hedging reserve | (853) | 1,575 |
Own credit reserve | (960) | (954) |
Other reserves and treasury shares | 1,126 | 964 |
Total | 1,770 | 4,461 |
Measure | Definition |
Loan: deposit ratio | Loans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on page 46. |
Period end allocated tangible equity | Allocated tangible equity is calculated as 13.5% (2020: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses. |
Average tangible shareholders’ equity | Calculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period. |
Average allocated tangible equity | Calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. |
Return on average tangible shareholders’ equity | Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 70 to 72. |
Return on average allocated tangible equity | Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 70 to 73. |
Cost: income ratio | Total operating expenses divided by total income. |
Loan loss rate | Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 29. Quoted as zero when credit impairment is a net release. |
Net interest margin | Net interest income divided by the sum of average customer assets. The components of the calculation have been included on pages 24 to 25. |
Tangible net asset value per share | Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 74. |
Profit/(loss) attributable to ordinary equity holders of the parent | Average tangible equity | Return on average tangible equity | |||
For the year ended 31.12.21 | £m | £bn | % | ||
Barclays UK | 1,756 | 10.0 | 17.6 | ||
Corporate and Investment Bank | 4,202 | 28.3 | 14.9 | ||
Consumer, Cards and Payments | 615 | 4.1 | 15.0 | ||
Barclays International | 4,817 | 32.4 | 14.9 | ||
Head Office | (198) | 5.0 | n/m | ||
Barclays Group | 6,375 | 47.4 | 13.4 | ||
For the year ended 31.12.20 | |||||
Barclays UK | 325 | 10.1 | 3.2 | ||
Corporate and Investment Bank | 2,554 | 27.0 | 9.5 | ||
Consumer, Cards and Payments | (334) | 4.5 | (7.5) | ||
Barclays International | 2,220 | 31.5 | 7.1 | ||
Head Office | (1,019) | 6.7 | n/m | ||
Barclays Group | 1,526 | 48.3 | 3.2 |
Year ended 31.12.21 | ||||||
Barclays UK | Corporate and Investment Bank | Consumer, Cards and Payments | Barclays International | Head Office | Barclays Group | |
Return on average tangible shareholders' equity | £m | £m | £m | £m | £m | £m |
Attributable profit/(loss) | 1,756 | 4,202 | 615 | 4,817 | (198) | 6,375 |
£bn | £bn | £bn | £bn | £bn | £bn | |
Average shareholders' equity | 13.6 | 28.3 | 4.8 | 33.1 | 8.7 | 55.4 |
Average goodwill and intangibles | (3.6) | — | (0.7) | (0.7) | (3.7) | (8.0) |
Average tangible shareholders' equity | 10.0 | 28.3 | 4.1 | 32.4 | 5.0 | 47.4 |
Return on average tangible shareholders' equity | 17.6% | 14.9% | 15.0% | 14.9% | n/m | 13.4% |
Year ended 31.12.20 | ||||||
Barclays UK | Corporate and Investment Bank | Consumer, Cards and Payments | Barclays International | Head Office | Barclays Group | |
Return on average tangible shareholders' equity | £m | £m | £m | £m | £m | £m |
Attributable profit/(loss) | 325 | 2,554 | (334) | 2,220 | (1,019) | 1,526 |
£bn | £bn | £bn | £bn | £bn | £bn | |
Average shareholders' equity | 13.7 | 27.0 | 5.1 | 32.1 | 10.6 | 56.4 |
Average goodwill and intangibles | (3.6) | — | (0.6) | (0.6) | (3.9) | (8.1) |
Average tangible shareholders' equity | 10.1 | 27.0 | 4.5 | 31.5 | 6.7 | 48.3 |
Return on average tangible shareholders' equity | 3.2% | 9.5% | (7.5)% | 7.1% | n/m | 3.2% |
Barclays Group | |||||||||
Return on average tangible shareholders' equity | Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | |
£m | £m | £m | £m | £m | £m | £m | £m | ||
Attributable profit | 1,117 | 1,446 | 2,108 | 1,704 | 220 | 611 | 90 | 605 | |
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Average shareholders' equity | 56.3 | 56.6 | 54.4 | 54.4 | 55.7 | 56.4 | 58.4 | 55.2 | |
Average goodwill and intangibles | (8.1) | (8.2) | (7.9) | (7.9) | (8.1) | (8.1) | (8.2) | (8.2) | |
Average tangible shareholders' equity | 48.2 | 48.4 | 46.5 | 46.5 | 47.6 | 48.3 | 50.2 | 47.0 | |
Return on average tangible shareholders' equity | 9.3% | 11.9% | 18.1% | 14.7% | 1.8% | 5.1% | 0.7% | 5.1% |
Barclays UK | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | |
Attributable profit/(loss) | 420 | 317 | 721 | 298 | 160 | 113 | (123) | 175 | |
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Average allocated equity | 13.6 | 13.6 | 13.5 | 13.5 | 13.4 | 13.7 | 13.9 | 13.7 | |
Average goodwill and intangibles | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | |
Average allocated tangible equity | 10.0 | 10.0 | 9.9 | 9.9 | 9.8 | 10.1 | 10.3 | 10.1 | |
Return on average allocated tangible equity | 16.8% | 12.7% | 29.1% | 12.0% | 6.5% | 4.5% | (4.8)% | 6.9% |
Barclays International | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | |
Attributable profit | 856 | 1,263 | 1,267 | 1,431 | 441 | 782 | 468 | 529 | |
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Average allocated equity | 33.8 | 32.7 | 33.0 | 32.8 | 31.1 | 31.2 | 34.2 | 31.9 | |
Average goodwill and intangibles | (0.9) | (0.9) | (0.6) | (0.5) | (0.6) | (0.6) | (0.7) | (0.7) | |
Average allocated tangible equity | 32.9 | 31.8 | 32.4 | 32.3 | 30.5 | 30.6 | 33.5 | 31.2 | |
Return on average allocated tangible equity | 10.4% | 15.9% | 15.6% | 17.7% | 5.8% | 10.2% | 5.6% | 6.8% |
Corporate and Investment Bank | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | |
Attributable profit | 733 | 1,157 | 1,049 | 1,263 | 413 | 627 | 694 | 820 | |
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Average allocated equity | 28.7 | 27.8 | 28.4 | 28.2 | 26.3 | 26.4 | 29.1 | 26.2 | |
Average goodwill and intangibles | — | — | — | — | — | — | (0.1) | — | |
Average allocated tangible equity | 28.7 | 27.8 | 28.4 | 28.2 | 26.3 | 26.4 | 29.0 | 26.2 | |
Return on average allocated tangible equity | 10.2% | 16.6% | 14.8% | 17.9% | 6.3% | 9.5% | 9.6% | 12.5% |
Consumer, Cards and Payments | |||||||||
Q421 | Q321 | Q221 | Q121 | Q420 | Q320 | Q220 | Q120 | ||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | |
Attributable profit/(loss) | 123 | 106 | 218 | 168 | 28 | 155 | (226) | (291) | |
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Average allocated equity | 5.1 | 4.9 | 4.6 | 4.6 | 4.8 | 4.8 | 5.1 | 5.7 | |
Average goodwill and intangibles | (0.9) | (0.9) | (0.6) | (0.5) | (0.6) | (0.6) | (0.6) | (0.7) | |
Average allocated tangible equity | 4.2 | 4.0 | 4.0 | 4.1 | 4.2 | 4.2 | 4.5 | 5.0 | |
Return on average allocated tangible equity | 11.7% | 10.5% | 21.8% | 16.5% | 2.7% | 14.7% | (20.2)% | (23.5)% |
Tangible net asset value per share | As at 31.12.21 | As at 31.12.20 |
£m | £m | |
Total equity excluding non-controlling interests | 69,222 | 65,797 |
Other equity instruments | (12,259) | (11,172) |
Goodwill and intangibles | (8,061) | (7,948) |
Tangible shareholders' equity attributable to ordinary shareholders of the parent | 48,902 | 46,677 |
m | m | |
Shares in issue | 16,752 | 17,359 |
p | p | |
Tangible net asset value per share | 292 | 269 |
Results timetable1 | Date | ||||||
Ex-dividend date | 3 March 2022 | ||||||
Dividend record date | 4 March 2022 | ||||||
Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-investment Programme (DRIP) Application Form Mandate | 18 March 2022 | ||||||
Dividend payment date | 5 April 2022 | ||||||
Q1 2022 Results Announcement | 28 April 2022 | ||||||
For qualifying US and Canadian resident ADR holders, the 2021 full year dividend of 4.0p per ordinary share becomes 16.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above. | |||||||
Year ended | Year ended | ||||||
Exchange rates2 | 31.12.21 | 31.12.20 | % Change3 | ||||
Period end - USD/GBP | 1.35 | 1.37 | (1)% | ||||
Average - USD/GBP | 1.38 | 1.28 | 8% | ||||
3 month average - USD/GBP | 1.35 | 1.32 | 2% | ||||
Period end - EUR/GBP | 1.19 | 1.12 | 6% | ||||
Average - EUR/GBP | 1.16 | 1.13 | 3% | ||||
3 month average - EUR/GBP | 1.18 | 1.11 | 6% | ||||
Share price data | |||||||
Barclays PLC (p) | 187.00 | 146.68 | |||||
Barclays PLC number of shares (m) | 16,752 | 17,359 | |||||
For further information please contact | |||||||
Investor relations | Media relations | ||||||
Chris Manners +44 (0) 20 7773 2136 | Tom Hoskin +44 (0) 20 7116 4755 | ||||||
More information on Barclays can be found on our website: home.barclays. | |||||||
Registered office | |||||||
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | |||||||
Registrar | |||||||
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | |||||||
Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas. | |||||||
American Depositary Receipts (ADRs) | |||||||
Shareowner Services | |||||||
StockTransfer@equiniti.com | |||||||
Tel: +1 800 990 1135 (toll free in US and Canada), +1 651 453 2128 (outside the US and Canada) | |||||||
Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA. | |||||||
Delivery of ADR certificates and overnight mail | |||||||
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120, USA. | |||||||
Qualifying US and Canadian resident ADR holders should contact Shareowner Services for further details regarding the DRIP |
1 | Note that these dates are provisional and subject to change. |
2 | The average rates shown above are derived from daily spot rates during the year. |
3 | The change is the impact to GBP reported information. |
4 | Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales. |